PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases (English)
- New search for: Scalone, L.
- New search for: Cortesi, P. A.
- New search for: Ciampichini, R.
- New search for: Okolicsanyi, S.
- New search for: Rota, M.
- New search for: Ciaccio, A.
- New search for: Ideo, G.
- New search for: Colledan, M.
- New search for: Belli, L. S.
- New search for: Cesana, G.
- New search for: Scalone, L.
- New search for: Cortesi, P. A.
- New search for: Ciampichini, R.
- New search for: Okolicsanyi, S.
- New search for: Rota, M.
- New search for: Ciaccio, A.
- New search for: Ideo, G.
- New search for: Colledan, M.
- New search for: Belli, L. S.
- New search for: Cesana, G.
In:
VALUE IN HEALTH
;
15
, 7
;
A332
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases
-
Contributors:Scalone, L. ( author ) / Cortesi, P. A. ( author ) / Ciampichini, R. ( author ) / Okolicsanyi, S. ( author ) / Rota, M. ( author ) / Ciaccio, A. ( author ) / Ideo, G. ( author ) / Colledan, M. ( author ) / Belli, L. S. ( author ) / Cesana, G. ( author )
-
Published in:VALUE IN HEALTH ; 15, 7 ; A332
-
Publisher:
- New search for: Blackwell Publishing Ltd
-
Publication date:2012-01-01
-
Size:A332
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 15, Issue 7
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- A278
-
PR2 Guiding Principles for Providing Effective Access to Medicines in Emerging MarketsShankar, R. / Hickson, S. et al. | 2012
- A282
-
MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes: Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer TherapiesFrederix, G. W. / Van hasselt, J. G. / Schellens, J. H. / Hö / vels, A. M. / Huitema, A. D. / Raaijmakers, J. A. / Severens, J. et al. | 2012
- A283
-
PA3 Limited Access to Cataract Surgery in PolandSzmurlo, D. / Fundament, T. / Kopec, G. / Brzyski, D. / Wladysiuk, M. / Landa, K. et al. | 2012
- A285
-
CL2 Statistical Considerations in Estimating Survival for Economic Evaluations in OncologyKhan, N. / Shah, D. / Briggs, A. / Park, J. / Huang, H. / Hawkins, N. et al. | 2012
- A286
-
DU3 Market Access Delays for CNS Drugs in EuropeFlostrand, S. J. / Anderson, L. / Esposito, G. et al. | 2012
- A287
-
RE4 Beyond the Evidence - The Influence of Decision Processes on Outcomes in Coverage Determination of Health TechnologiesFischer, K. E. / Rogowski, W. H. / Leidl, R. / Stollenwerk, B. et al. | 2012
- A288
-
PHP1 Incorporating the Patient's Voice Into the Assessment of Medical Devices: A Comparison of the United States and EuropeDoward, L. / Whalley, D. / Houghton, K. / DeMuro, C. / Evans, E. / Gnanasakthy, A. et al. | 2012
- A289
-
PHP7 How Do Reimbursement Systems Encourage or Inhibit Adoption of Innovative Medical Devices in an Ambulatory Setting?Wilkinson, G. / Drummond, M. et al. | 2012
- A290
-
PHP12 Patented Drug Extension Strategies on Health Care Spending: A Cost-Evaluation AnalysisVernaz, N. / Haller, G. / Girardin, F. / Huttner, B. / Dayer, P. / Muscionico, D. / Salomon, J. L. / Bonnabry, P. et al. | 2012
- A291
-
PHP18 The Effect of Law for Economical Use of Medications 2006 on the Catchment Population of Community Pharmacies Between 2007-2010Boncz, I. / Donka-Verebes, x. / Oberfrank, F. et al. | 2012
- A292
-
PHP23 The Early Benefit Assessment of New Pharmaceuticals in Germany (“AMNOG”): A Structured Survey Analysis One Year After EnactmentStoeckel, F. / Neubauer, A. S. et al. | 2012
- A294
-
PHP34 France Market Access: Review of 2011-2012 Assessments by Transparency CommitteeAggarwal, S. et al. | 2012
- A295
-
PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars: The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth HormonesFrenzel, A. / Schmidt, N. / Grahl, J. et al. | 2012
- A297
-
PHP51 Perception of Parallel Trade of Pharmaceuticals in Poland – Results of National Market ResearchBaran-Lewandowska, I. / Hermanowski, T. et al. | 2012
- A298
-
PHP57 Emerging Drug Reimbursement Models: Lessons and Implications from Cancer Drug Access SchemesAggarwal, S. et al. | 2012
- A299
-
PHP63 Potential Effects of Changes in Pricing Regulations Between 2004 and 2011 on the Turkish Pharmaceutical IndustryMemis, S. A. / Deger, C. / Marmarali, B. / Parali, E. / Sumer, F. / Karakeben, K. / Kayadibinli, M. / Cetinelli, S. T. et al. | 2012
- A300
-
PHP68 The Effect of Resetting the Clock in Health CareGresz, M. / Varga, S. / Sebestyé / n, A. / Toldi, J. / Bogá / r, L. / Molics, B. / Boncz, I. et al. | 2012
- A301
-
PHP74 Cost-of-Illness of Patient-Reported Adverse Drug Events – a Population-Based SurveyGyllensten, H. / Rehnberg, C. / Jö / nsson, A. K. / Petzold, M. / Carlsten, A. / Andersson Sundell, K. et al. | 2012
- A303
-
PHP86 Cost-Effectiveness in Health Care Programs: A Literature ReviewVanhaute, O. A. / Annemans, L. et al. | 2012
- A304
-
PHP91 Is There an Overuse of Computed Tomography (CT) Scanning of Patients in United States Hospitals? A Review of the EvidenceWang, Z. / Boswell, E. / Kokkotos, F. K. / Dong, X. / Liu, Y. / Tong, H. / Xiao, H. et al. | 2012
- A305
-
PHP97 The Regional Distribution of Disabled Pensioners of HungaryTurcsanyi, K. / Pakai, A. / Szabó / J. / Olá / h, A. / Gombos, G. / Gresz, M. / Molics, B. / Boncz, I. et al. | 2012
- A306
-
PHP102 Patient Satisfaction with Pharmacies ConditionRasekh, H. / Rangchian, M. / Mehralian, G. / Bagherian, S. J. et al. | 2012
- A307
-
PHP107 Experts' Views on the Introduction of a Monopsony in Health Care Services in GreeceSkroumpelos, A. / Zavras, D. / Pavi, E. / Kyriopoulos, J. et al. | 2012
- A309
-
PHP118 Estimating the Probability of a Recommendation for Reimbursement for a New Drug in the UK Using an MCDA ApproachWilliams, P. / Mauskopf, J. A. / Kilburg, A. / Lebiecki, J. et al. | 2012
- A310
-
PHP124 Comparison of HTA Dossier Requirements Across EuropeCasamayor, M. / Van Engen, A. et al. | 2012
- A311
-
PHP130 Guidelines Without Guidance: The Case of Epidemiological Data Beyond Clinical TrialsSandmann, F. G. / Herrmann, K. H. / Zhou, M. / Gerber, A. / Lhachimi, S. K. et al. | 2012
- A312
-
PHP135 Stakeholders's Views of the Social Insurance Reform in GreeceMylona, K. / Skroumpelos, A. / Tsiantou, V. / Karampli, E. / Pavi, E. / Kyriopoulos, J. et al. | 2012
- A313
-
PHP141 Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies in TurkeyKockaya, G. / Daylan Kockaya, P. / Ergin Oguzhan, G. et al. | 2012
- A314
-
PHP146 Pharmacoeconomic Education for Pharmacy Students in the Russian FederationMakhinova, T. / Makhinova, E. N. / Rascati, K. L. et al. | 2012
- A315
-
PHP152 The Early Benefit Assessment of Drugs That are Launched Before 2011Weber, B. et al. | 2012
- A316
-
PHP157 To What Extent Does the Federal Joint Committee Follows the Evidence Based Recommendations by IQWiGWeber, B. / Schmitter, S. / Schiffner-Rohe, J. et al. | 2012
- A317
-
PHP162 Review of NICE's Technology Appraisal RecommendationsRinaldi, F. / George, E. / Longson, C. et al. | 2012
- A318
-
PHP169 Comparing the Hungarian Methodological Guideline for Conducting Economic Evaluation of Health Care Intervention with European GuidelinesHuszti, Z. / Nagy, B. Z. et al. | 2012
- A319
-
PHP174 Physical Activity Matters: The Associations Between Body Mass Index, Physical Activity and Health-Realted Quality-of-Life Trajectories Over 10 YearsFeeny, D. H. / Garner, R. / Bernier, J. / Thompson, A. / Mcfarland, B. H. / Huguet, N. / Kaplan, M. S. / Ross, N. A. / Blanchard, C. et al. | 2012
- A322
-
PHP190 Global Pharmaceutical Risk-Sharing Agreement Trends in 2011 and 2012: Slowing Down?Ando, G. / Izmirlieva, M. / Honoré / A. C. et al. | 2012
- A323
-
PHP195 Adoption of New Technologies in Twenty Established and Emerging MarketsHertz, D. / Marcarelli, A. D. / Patel, L. / Garfield, S. et al. | 2012
- A324
-
PHP201 Can Risk Management Plans (RMP) Contribute to Health Technology Assessment (HTA) and Knowledge of Safety in Everyday Medical Practice?Prieto, L. / Spooner, A. / Hidalgo-Simon, A. / Rubino, A. / Kurz, X. / Arlett, P. et al. | 2012
- A325
-
PHP206 Assessing the Value of Access to Individual Patient Data for Reimbursement DecisionsManca, A. et al. | 2012
- A326
-
PGI5 Effectiveness and Safety of Antacids in Pregnant Women Suffering From Gerd/Hyperacidity SymptomsDonde, S. et al. | 2012
- A328
-
PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)Humphreys, S. C. / Elbasha, E. H. / Ferrante, S. A. / Lion, M. / O'Regan, C. et al. | 2012
- A329
-
PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-UpOdes, S. / Greenberg, D. / Vardi, H. / Friger, M. / Stockbrugger, R. / Munkholm, P. et al. | 2012
- A330
-
PGI27 Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults With Irritable Bowel Syndrome With ConstipationBuono, J. L. / Tourkodimitris, S. / Sarocco, P. / Baird, M. J. / Johnston, J. M. / Carson, R. et al. | 2012
- A331
-
PGI32 New Antiviral Drugs for Hepatitis C in Italy: Will it be a Treasure Hunt?Gardini, I. / Fontana, R. / Fumagalli, M. / Conforti, M. / Lanati, E. P. et al. | 2012
- A332
-
PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's DiseaseArnould, B. / Fofana, F. / Gilet, H. / Colombel, J. F. / Faure, P. / Hagè / ge, H. / Nachury, M. / Nahon, S. / Tucat, G. et al. | 2012
- A333
-
PMH2 Interim Results From the “AUTOR” Study, a European Observational Study in Pediatric Patients With Attention Deficit/Hyperactivity Disorder: Patient Characteristics and 1-Year CostsHaynes, V. / Quail, D. / Lorenzo, M. / Deix, C. / Anand, H. et al. | 2012
- A334
-
PMH8 Cost of Methylphenidate and Atomoxetine Prescribing to Children and Adults in South AfricaTruter, I. et al. | 2012
- A335
-
PMH13 Longitudinal Analysis of Patient Level Health Care Costs in Patients With Major Depressive Disorder Treated With DuloxetineCui, Z. / Faries, D. E. / Shen, W. / Able, S. L. / Novick, D. et al. | 2012
- A336
-
PMH18 Treatment Patterns and Costs in Patients With Schizophrenia in GermanyZeidler, J. / Heres, S. / Mahlich, J. C. / Greiner, W. et al. | 2012
- A337
-
PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in FinlandEinarson, T. R. / Pudas, H. / Zilbershtein, R. / Jensen, R. / Nielsen, A. T. / Piwko, C. / Hemels, M. / Vincente, C. et al. | 2012
- A338
-
PMH28 Using Cost-Effectiveness Analysis to Define the Optimal Group of Patients to Benefit From Risperidone Long-Acting InjectableValencia-Mendoza, A. / Herná / ndez-Garduñ / o, A. et al. | 2012
- A339
-
PMH33 Cost Effectiveness of Paliperidone Palmitate Versus Oral Medication in the Treatment of Schizophrenia in AustriaWalter, E. / Dragosits, A. / Said, M. et al. | 2012
- A340
-
PMH38 Assessing Depressive Symptoms in Primary Care: Psychometrical Properties of the Spanish Version of the Clinically Useful Depression Outcome ScaleAgü / era, L. / Monton, C. / Maurino, J. / Medina, E. / Diaz, H. / Cuervo, J. et al. | 2012
- A341
-
PMH43 Modelling the Longitudinal Latent Effect of Pregabalin on Self-Reported Changes in Sleep Disturbances and Disability in Outpatients With Generalized Anxiety Disorder (GAD) Treated in Routine Clinical Practice in SpainRuiz, M. A. / Alvarez, E. / Carrasco, J. L. / Olivares, J. M. / Pé / rez, M. / Rejas, J. et al. | 2012
- A342
-
PMH48 Public Beliefs and Attitudes About Schizophrenia, Major Depression and Psychotropic MedicationRefaï / T. / Millier, A. / Toumi, M. / Ré / muzat, C. / Angermeyer, M. C. et al. | 2012
- A343
-
PMH54 ADHD Among Adults in Five Western European Countries: An Analysis of National Health and Wellness Survey DataAble, S. L. / Haynes, V. / Annunziata, K. / Upadhyaya, H. / Deberdt, W. et al. | 2012
- A344
-
PMD1 Economic Value of Screening for Early Parkinson's Disease in a European SettingJohnson, S. / Birnbaum, H. G. / Kaltenboeck, A. / Diener, M. / Siderowf, A. et al. | 2012
- A345
-
PMD6 Extracorporeal Photopheresis for the Treatment of Patients With Acute or Chronic Graft Versus Host Disease (GvHD), Refractory to Corticosteroids – A Sytematic ReviewWalczak, J. / Miernik, K. / Kuter, I. / Ussowicz, M. et al. | 2012
- A346
-
PMD12 A Budget Impact Model to Investigate Potential Cost Savings Associated With the Use of Safety-Engineered Sharp Devices in BelgiumHanmore, E. / Ruff, L. / Maclaine, G. D. / Garin, F. / Leroy, N. et al. | 2012
- A347
-
PMD17 Use of Sterrad® Sterilizers Results in Cost-Savings Compared to Steam Sterilization in an Italian Hospital SettingPerrone, F. / Zenna, G. / Mauro, E. / Hamerslag, L. / Emmermann, A. et al. | 2012
- A349
-
PMD28 Comparing the Cost and Diagnostic Efficiency of Gadoxetic Acid-Enhanced MRI Versus Extracellular Contrast Media-Enhanced MRI and Multidetector Computed Tomography in Patients With Suspected Hepatocellular Carcinoma in Thailand and KoreaHoltorf, A. P. / Bergmann, K. / Kim, M. J. / Phongkitkarun, S. / Sobhonslidsuk, A. / Rinde, H. / Lee, J. M. et al. | 2012
- A350
-
PMD33 The Impact of Three Different Imaging Strategies on Surgery Planning for Patients With Colorectal Cancer Liver MetastasesRinde, H. / Zech, C. J. / Jonas, E. / Bergmann, K. / Holtorf, A. P. et al. | 2012
- A351
-
PMD38 The Cost Burden of Unexplained Syncope in Five European Countries: A Database AnalysisEggington, S. / Tsintzos, S. / Collignon, C. / Borghetti, F. / Martí / B. / Sicras-Mainar, A. et al. | 2012
- A352
-
PMD44 Evaluating Strategies for Using DNA Testing to Identify Mucinous Pancreatic CystsMyers, J. A. / Klein, R. W. / Han, X. / Al-Haddad, M. A. / Smolen, H. J. et al. | 2012
- A354
-
PMD55 Sacral Nerve Modulation (SNM) for the Treatment of Idiopathic Refractory Overactive Bladder: Cost-Effective in the UK Compared to Optimal Medical Therapy, Botulinum Toxin a (BoNT-A) and Percutaneous Tibial Nerve Stimulation (PTNS)Walleser, S. / Betts, C. / Hallas, N. / Ockrim, J. et al. | 2012
- A355
-
PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma: A Systematic ReviewZaim, R. / Redekop, W. K. / De Bree, R. / Van Dongen, G. A. / Hoekstra, O. S. / Uyl-de Groot, C. A. et al. | 2012
- A357
-
PMD72 The Use of Multi-Criteria Decision Analysis to Elicit Colorectal Cancer Screening PreferencesHummel, J. M. / Steuten, L. / Groothuis-Oudshoorn, K. G. / Mulder, N. / IJzerman, M. J. et al. | 2012
- A358
-
PMD77 Contribution of Individual EQ-5D Dimensions to Improved Quality of Life After Balloon Kyphoplasty for Vertebral Compression FracturesBorgströ / m, F. / Aghayev, E. / Olafsson, G. / Miltenburger, C. et al. | 2012
- A359
-
PMD82 Implantable Cardioverter Defibrillator in Italy From 2000 to 2008: A Population-Based Analysis Using Health Administrative DatabasesMadotto, F. / Fornari, C. / Conti, S. / Borghetti, F. / Mantovani, L. G. / Cesana, G. et al. | 2012
- A360
-
PMD88 Disparities in Access to EGFR-Mutation Testing in Patients With Advanced NSCLC in Germany 2011Kellermann, L. / Ukena, D. et al. | 2012
- A362
-
PCV6 Comparison Rivaroxaban with Other Antithrombotic Agents: Effectiveness and Safety of Prophylactic Antithrombotic Agents After Major Orthopedic Surgeries in TaiwanChang, W. Y. / Hsu, H. C. / Wu, C. H. / Chen, P. S. / Wu, M. T. et al. | 2012
- A363
-
PCV11 Indirect Treatment Comparison (ITC) of Novel Oral Anticoagulants for the Prevention of Thromboembolic Events in Patients With Atrial FibrillationPechlivanoglou, P. / Le, H. H. / Engelfriet, P. M. / Redekop, W. K. / Postma, M. J. et al. | 2012
- A364
-
PCV16 Use of ACE Inhibitors in Serbia in 2009 and 2010Milijasevic, B. / Tomic, Z. / Sabo, A. / Horvat, O. et al. | 2012
- A365
-
PCV22 A Simple Risk Score Identifies Individuals, in European Settings, More Likely to Incur Higher Medical CostsGuda, S. / Alperin, P. / Schuetz, C. A. et al. | 2012
- A366
-
PCV27 Pharmacoeconomic Evaluation of Neuroprotective Therapy of Patients With Acute Ischemic Stroke in UkraineMishchenko, O. / Iakovlieva, L. / Adonkina, V. / Chinush, I. / Matyashova, N. et al. | 2012
- A367
-
PCV32 The Cost of Diabetes Complications in BelgiumLamotte, M. / Chevalier, P. et al. | 2012
- A369
-
PCV43 Fair Cost-Benefit Evaluation of Health Care: A Case Study of Blood Pressure Lowering Drugs in FranceDormont, B. / Fleurbaey, M. / Luchini, S. / Samson, A. L. / Schokkaert, E. / Thé / baut, C. / Van de Voorde, C. et al. | 2012
- A370
-
PCV48 Systematic Review of Cost-Effectiveness Models for Pharmacologic Stroke Prevention in Atrial FibrillationLimone, B. / Baker, W. L. / Roberts, M. / Coleman, C. I. et al. | 2012
- A371
-
PCV53 Economic Evaluation of a Single Pill Triple Antihypertensive Therapy With Valsartan, Amlodipine, and Hydrochlorothiazide Against Its Dual Components in GreeceStafylas, P. / Kourlaba, G. / Hatzikou, M. / Georgiopoulos, D. / Maniadakis, N. et al. | 2012
- A373
-
PCV65 A Health Economic Evaluation of Omega-3 Acid Ethyl Esters 90 in the Secondary Prevention Post-MIGerlier, L. / Vellopoulou, K. / Lamotte, M. / Lacey, L. / Einroos, A. / Carr, E. et al. | 2012
- A374
-
PCV70 Cost-Effectiveness of Smoking Cessation Interventions in Smokers With Cardiovascular Disease in the NetherlandsMajer, I. M. / Rozenbaum, M. H. / Verheggen, B. et al. | 2012
- A376
-
PCV82 Observational Study Evaluating the Level of Compliance With Antihypertensive Drugs in the Greek PopulationGeorgiopoulos, D. / Hatzikou, M. / Demousis, F. / Sakalides, C. et al. | 2012
- A377
-
PCV87 Factors Related to Non-Adherence and Satisfaction for Hypertension Medications: Results From a Novel Patient RegistryKamble, S. / Cascade, E. / Gemmen, E. et al. | 2012
- A378
-
PCV92 Comparison of the Psychometric Properties of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) and the SF-36 in Patients with Pulmonary HypertensionTwiss, J. / Ganderton, L. / Jenkins, S. / Ben-L'amri, M. / Gain, K. / Fowler, R. / Gabbay, E. / McKenna, S. et al. | 2012
- A379
-
PCV97 Burden of Dyspepsia among Patients With Atrial Fibrillation in JapanKinoshita, Y. / DiBonaventura, M. D. / Wang, E. C. / Rossi, B. / Iwamoto, K. / Stankus, A. / Briere, J. B. et al. | 2012
- A380
-
PCV102 Characteristics Influencing Japanese Atrial Fibrillation Patients Preferences for Anticoagulants UseOkumura, K. / Inoue, H. / Yasaka, M. / Gonzalez, J. M. / Hauber, A. B. / Iwamoto, K. / Wang, E. C. / Rossi, B. / Briere, J. B. et al. | 2012
- A381
-
PCV108 Analysis of Outpatient Utilization and Costs of Antithrombotic Drugs in Poland – Implications for Pharmaceutical Pricing and Reimbursement PolicyBochenek, T. / Nizankowski, R. et al. | 2012
- A382
-
PCV113 The Utilisation of Statins in Slovak RepublicGatialova, K. / Bellova, K. / Foltan, V. / Majtá / s, J. et al. | 2012
- A383
-
PCV119 Retrospective Analysis of Pharmaceutical Expenditures in 2011 in the Republic of SrpskaGuzvic, V. / Zah, V. et al. | 2012
- A385
-
PIN7 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Complicated Skin and Soft Tissue Infections (CSSTI): A Network Meta-Analysis (NMA)Medic, G. / Karabis, A. / Borrill, J. / Worrall, J. / Bergman, G. et al. | 2012
- A386
-
PIN12 Burden of Disease and Serotype Distribution Associated With Reportable Invasive Streptococcus Pneumoniae Pneumonia in Norway, 2007–2009Raluy, M. / Gray, S. / Lambrelli, D. / Eriksson, D. / Samantha, M. / Wasiak, R. / Myrvang, B. et al. | 2012
- A387
-
PIN17 Tuberculosis Treatment Outcomes in Four States of MalaysiaKhan, A. H. / Syed Sulaiman, S. A. / Abdul Muttalif, A. R. / Hassali, M. A. / Ahmad, N. et al. | 2012
- A388
-
PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in FinlandMartikainen, J. A. / Soini, E. J. / Laine, J. / hman, H. / Postila, V. / Klemets, P. et al. | 2012
- A390
-
PIN33 Corsar-Study (Cost and Resource Utilisation Study in Antiretroviral Treated Patients)Stoll, M. / Kuhlmann, A. / Hower, M. / Heiken, H. / Gerschmann, S. / Klauke, S. / Lutz, T. / Bogner, J. / Degen, O. / van Lunzen, J. et al. | 2012
- A391
-
PIN38 Real Life Study of Antifungal Treatment in Greek ICUs: Therapeutic Strategy and Hospital Resource Utilization – Estimator StudyArmaganidis, A. / Nanas, S. / Antoniadou, E. / Mandragos, K. / Liakou, K. / Kostagiolas, L. / Koutsoukou, A. / Baltopoulos, G. / Nakos, G. / Magkina, A. et al. | 2012
- A392
-
PIN43 The Use of Futility Rules in Economic Evaluations With Direct Acting Agents (DAA) in the Treatment of Genotype 1 Hepatitis C Virus (HCV) From a Spanish Health Care PerspectiveD'Angelo, E. R. / Garcia Gonzalez, I. / Simon, M. A. et al. | 2012
- A393
-
PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security PerspectiveSantos, M. / Stenut, S. / Ferraq, W. / Legrand, J. C. / Tilleul, P. / Borget, I. et al. | 2012
- A394
-
PIN53 The Cost Effectiveness of Maternal and Infant Antiretroviral Regimens to Prevent Vertical Transmission in a Resource Poor CountryRevill, P. / Walker, S. / Sculpher, M. J. / Merry, C. / Barry, M. / Ryan, M. et al. | 2012
- A395
-
PIN59 Cost-Effectiveness of Amoxicillin Clavulanate Directed Towards the Application of Indicated at Primary Care in the Treatment of Community Acquired Pneumonia, Acute Rhinosinusitis, Tonsillopharyngitis, and Acute Otitis MediaMalhan, S. / Oksuz, E. / Eray, O. / Koc, E. et al. | 2012
- A396
-
PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoVac) in the UKJiang, Y. / Gauthier, A. / Keeping, S. T. / Carroll, S. M. et al. | 2012
- A397
-
PIN69 Cost Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in MalaysiaWu, D. B. / Lee, K. K. / Lee, V. W. / Hong, L. W. / Roberts, C. S. et al. | 2012
- A398
-
PIN74 Cost Savings Due to Antibiotic Prescription Related to Quick C-Reactive Protein TestingTesar, T. / Babela, R. et al. | 2012
- A399
-
PIN80 Multivariate Cox Analysis Regarding Treatment Switch on Chronic Hepatitis B (CHB) Disease Management Based on a 2-Year Prospective Study in 5 European (EU) CountriesArama, V. / Zeuzem, S. / Leblebicioglu, H. / Simon, K. / Klauck, I. / Morais, E. / Lescrauwaet, B. / Kamar, D. / Zarski, J. et al. | 2012
- A401
-
PIN90 Towards Best Practices for Handling Uncertainties in Health Technology Assessments for HPV Vaccination to Better Inform Decision MakingSiebert, U. / Castellsague, X. / Lee Mortensen, G. / La Torre, G. et al. | 2012
- A402
-
PSU5 Bariatric Surgery From the Perspective of Brazilian National Health System (SUS)Freitas, M. G. / Souza, K. M. / Silva, M. T. / Elias, F. T. et al. | 2012
- A403
-
PSU10 Costs of Cardiovascular Readmissions Following Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease: Data From a Large Multi-Centre Australian RegistryAriyaratne, T. V. / Ademi, Z. / Duffy, S. J. / Andrianopoulos, N. / Billah, B. / Brennan, A. L. / Clark, D. J. / New, G. / Black, A. / Ajani, A. E. et al. | 2012
- A404
-
PSU15 Clinical and Economic Burden of Anastomotic Leaks After Colorectal SurgeriesLim, S. / Hammond, J. / Wan, Y. / Gao, X. / Patkar, A. et al. | 2012
- A405
-
PSU21 Sentinel Lymph Node Biopsy Less Expensive Than Axillary Lymph Node Dissection in Early Breast Cancer StagingRaimond, V. et al. | 2012
- A406
-
PSU26 Health-Related Quality of Life in Familial Amyloidotic Polyneuropathy Before and After Liver Transplantation: A Systematic Literature ReviewAmaral, L. M. / Fernandes, R. A. / Vasconcellos, J. F. / Takemoto, M. / Fujii, R. K. / Furlan, F. / Mould, J. et al. | 2012
- A407
-
PSU31 The Association Between Degenerative Disk Disease and Outcomes Among Patients Undergoing Lumbar Fusion SurgeryLage, M. J. / Kemner, J. E. / Mccormack, M. / Treglia, M. et al. | 2012
- A408
-
PCN1 Use of the 5-HT3-RA Antiemetics in the Prevention and Treatment of Radiation Induced Nausea and VomitingKnoth, R. L. / Faria, C. / Chang, E. / Broder, M. et al. | 2012
- A409
-
PCN6 The Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practicede Groot, S. / Redekop, W. / Oosting, S. / Oosterwijk, E. / Kiemeney, L. / Uyl-de Groot, C. et al. | 2012
- A410
-
PCN11 The Impact of Treatment Persistence With Lenalidomide (LEN) for the Treatment of Multiple Myeloma (MM) on Disease ControlHenk, H. / Kaura, S. / Khan, Z. / Teitelbaum, A. et al. | 2012
- A411
-
PCN17 Indirect Comparison of the Efficacy of Erlotinib Versus Pemetrexed Plus Cisplatin as First Line Treatment in Patients With Metastatic Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating MutationsPereira, C. / Sanches, M. / Loff, J. F. et al. | 2012
- A413
-
PCN29 Initial Treatment and Survival Among Elderly Patients With Advanced Breast Cancer by Estrogen Receptor and Progesterone Receptor Status: An Analysis of United States National Registry Data 2000-2009Lang, K. / Huang, H. / Namjoshi, M. / Federico, V. / Menzin, J. et al. | 2012
- A414
-
PCN34 Relationship Between Progression-Free Survival and Overall Survival in Chronic Lymphocytic LeukemiaBeauchemin, C. / Johnston, J. / Lapierre, M. E. / Aissa, F. / Lachaine, J. et al. | 2012
- A416
-
PCN45 Economic Evaluation of Using Branded Taxotere® Versus Generic Docetaxel: Based on Decision Tree ModelAl Ameri, M. N. / Tucker, A. / Johnston, A. et al. | 2012
- A417
-
PCN50 Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart ReviewKim, K. / Hernlund, E. / Justo, N. / Hernadi, Z. / Pete, I. / Ré / vé / sz, J. / Szá / nthó et al. | 2012
- A418
-
PCN56 Preliminary Results from a Study of Hospital Costs Due to Treatment of Head and Neck Cancers in EnglandTempest, M. J. / Thurston, S. / Carroll, S. M. / Keeping, S. T. et al. | 2012
- A419
-
PCN61 Melody Brazil – Resource Use and Associated Costs With Metastatic Melanoma in Brazilian Health Care SystemStefani, S. D. / Nita, M. E. / Nunes, J. / Campos, E. / Schmerling, R. A. / Barrios, C. / Dzik, C. / Alves, J. S. / Johnston, K. / Donato, B. M. et al. | 2012
- A420
-
PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UKBotteman, M. F. / Carter, J. A. / Fishman, P. / Chandiwana, D. / Bains, M. / Snedecor, S. J. et al. | 2012
- A421
-
PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in SpainMoreno, V. / Martí / nez-Amores, B. / Barriuso, J. / Mezquita, L. / Ibá / ez de Cá / ceres, I. / Ayuso, x. / Peñ et al. | 2012
- A422
-
PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of ChemotherapyCobo, M. / De Castro, J. / Isla, D. / Oyagü / ez, I. / Lozano, V. / Castro-Gomez, A. et al. | 2012
- A423
-
PCN81 Cost Effectiveness of Pazopanib in Soft Tissue SarcomaAmdahl, J. / Manson, S. / Isbell, R. / Chit, A. N. / Diaz, J. R. / Lewis, L. / Delea, T. E. et al. | 2012
- A424
-
PCN86 Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care SystemPereira, M. L. / Bahmdouni, L. S. / Pepe, C. / Teich, V. et al. | 2012
- A426
-
PCN97 Pharmacoeconomic Analysis of the Prostate Cancer Therapy with Gonadotropin-Releasing Hormone Analogues: Leuprorelin, Goserelin, TriptorelinOmelyanovsky, V. / Avxentyeva, M. / Ivakhnenko, O. / Khailov, P. / Krysanov, I. / Maksimova, L. et al. | 2012
- A427
-
PCN102 The Cost of Absenteeism and Short-Term Disability Associated With Colorectal Cancer: A Case-Control StudyYaldo, A. / Seal, B. / Lage, M. J. et al. | 2012
- A428
-
PCN107 Persistence in First Line Treatment of Metastatic Renal Cell Carcinoma in Routine Care in GermanyMergenthaler, U. / Morawski, E. / Wendschlag, A. et al. | 2012
- A429
-
PCN112 Characteristics of Cancer Patients Who Seek Cytostatic Therapy in Korea: A Pilot StudyKim, E. H. / Park, S. / Lee, J. S. / Choi, H. S. / Kim, K. S. / Kim, S. / Choi, W. C. et al. | 2012
- A430
-
PCN117 Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab: A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis AloneSalek, M. S. / Deger, M. / Wimberger, P. / Gilet, H. / Parsons, S. L. et al. | 2012
- A431
-
PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer PatientsJohnson, P. / Bancroft, T. J. / Barron, R. / Legg, J. / Watson, H. / Naeim, A. / Watkins, A. / Marshall, D. et al. | 2012
- A432
-
PCN127 Policy Maker, Please Carefully Consider Your Needs: Does Outcomes Research of Bortezomib for Advanced Multiple Myeloma Reduce Uncertainty?Franken, M. G. / Gaultney, J. G. / Blommestein, H. M. / Huijgens, P. C. / Sonneveld, P. / Redekop, W. K. / Uyl-de Groot, C. A. et al. | 2012
- A433
-
PCN133 Utilisation of Antineoplatic Agents Involved in Treatment of NSCLC in Slovak Republic Within 2008-2011Bellova, K. / Gatialova, K. / Foltan, V. / Majtá / s, J. et al. | 2012
- A434
-
PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving ChemotherapyZong, J. H. / Eckert, L. / Zhang, L. / Dai, W. S. / Lyman, G. H. / Cohen, A. T. et al. | 2012
- A435
-
PCN143 Utility Data in Appraisals of Oncology Drugs by the UK National Institute for Health and Clinical ExcellenceProudfoot, C. et al. | 2012
- A436
-
PCN149 Uncertainty Regarding NICE's End-of-Life Small Patient Population CriteriaMoï / se, P. / Sweeney, N. / Holmstrom, S. et al. | 2012
- A437
-
PCN154 Are Population-Based Registries a Suitable Tool for Outcomes Research in Cancer? Experiences from Four Registriesde Groot, S. / Blommestein, H. / Franken, M. / Uyl-de Groot, C. et al. | 2012
- A438
-
PCN159 Melody Brazil - Treatment Patterns in Brazilian Health Care SystemSchmerling, R. A. / Barrios, C. / Nita, M. E. / Stefani, S. D. / Campos, E. / Nunes, J. / Biasi, L. / Lima, L. / Dzik, C. / Johnston, K. et al. | 2012
- A439
-
PMS5 Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-to-Severe Rheumatoid ArthritisHicks, K. A. / Earnshaw, S. R. / Shaw, J. W. / Cifaldi, M. et al. | 2012
- A440
-
PMS10 Comparing Costs of Anti-TNF Therapy by Adminstration Route for Patients With Ankylosing Spondylitis and Rheumatoid Arthritis in France in 2012: A Budget Impact ModelChevreul, K. / Bourguignon, S. / Granados, D. et al. | 2012
- A442
-
PMS21 Determinants of Total Health Care Costs Associated With Rheumatoid Arthritis Prevalent Cases in TurkeyBaser, O. / Burkan, A. / Baser, E. / Koselerli, R. / Ertugay, E. / Altinbas, A. et al. | 2012
- A443
-
PMS26 Assessment of the Burden of Rheumatoid Arthritis in France: Analysis of a National Representative Claim DatabaseFagnani, F. / Laurendeau, C. / Fautrel, B. / Joubert, J. M. / De chalus, T. / Gourmelen, J. et al. | 2012
- A444
-
PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in ItalyMarcellusi, A. / Bansback, N. / Rao, S. / Cifaldi, M. / Gitto, L. / Giannantoni, P. / Russo, S. / Mennini, F. S. et al. | 2012
- A445
-
PMS36 Cost-Effectiveness of Denosumab for the Treatment of Elderly Women With Post-Menopausal Osteoporosis in SwedenLundkvist, J. / Lö / thgren, M. / Badamgarav, E. / Freyschyss, B. et al. | 2012
- A446
-
PMS41 Cost-Effectiveness of Denosumab in Preventing Osteoporotic Fractures in Postmenopausal Women from the Private Health Care Setting Perspective in BrazilBarbosa, E. G. / Machado, M. / Araú / jo, G. T. / Etto, H. / Fonseca, M. / Olimpio, A. et al. | 2012
- A448
-
PMS52 Drug Use Profile in a Rheumatoid Arthritis Patient Cohort: A Brazilian Health Management Organization ExperienceCantanheda, C. R. / Simas, H. S. / Dias, Q. C. et al. | 2012
- A449
-
PMS57 Effect of Different Methods on Estimating Persistence to Oral Bisphosphonate Therapy in Portuguese PMO Patients – an Observational Prospective StudyGuerreiro, J. / Torre, C. / Mendes, Z. / Machado, M. / Ferreira, I. / Feudjo-tepie, M. / Canhã / o, H. / Branco, J. / Miranda, A. et al. | 2012
- A450
-
PMS62 Nominal Group Technique to Select Attributes for Discrete Choice ExperimentsHiligsmann, M. / Van durme, C. / Geusens, P. / Dellaert, B. / Dirksen, C. / Van der Weijden, T. / Reginster, J. Y. / Boonen, A. et al. | 2012
- A451
-
PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension StudyStrand, V. / Purcaru, O. / Van vollenhoven, R. / Choy, E. / Fleischmann, R. et al. | 2012
- A452
-
PMS72 Adherence and Change of Opioid Use After Initiating Duloxetine or Celecoxib Among Patients With OsteoarthritisPeng, X. / Wu, N. / Chen, S. Y. / Yu, X. / Andrews, J. S. / Novick, D. et al. | 2012
- A453
-
PMS77 Real-World Comparison of Health Care Utilization Between Duloxetine Initiators and Pregabalin Initiators Among Fibromyalgia PatientsPeng, X. / Sun, P. / Wu, A. / Andrews, J. S. / Novick, D. / Faries, D. / Sun, S. et al. | 2012
- A454
-
PMS82 US Treatment Patterns in Psoriatic Arthritis Newly Initiated on Etanercept or AdalimumabZhang, F. / Li, S. / Curtis, J. R. et al. | 2012
- A455
-
PUK5 Employment Rates and Indirect Costs in Patients With End-Stage Renal Disease: Differences Between Modalities of Renal Replacement TherapyJuliá / n, J. C. / Cuervo, J. / Rebollo, P. / Castejó / n, N. / Callejo, D. et al. | 2012
- A456
-
PUK10 Comparative Cost-Analysis of Six Anticholinergics for the Treatment of Overactive Bladder and Incontinence in GermanyMayrhofer, T. / Grabe, K. / Felder, S. et al. | 2012
- A457
-
PUK15 Sevelamer in Early Stages Nondialysis-Dependent Chronic Kidney Disease (NDD-CKD) Dominates Calcium Carbonate Through Reduction of Deaths and HospitalizationsRuggeri, M. / Di Iorio, B. et al. | 2012
- A458
-
PUK21 Conversion From Epoetin Alfa to Darbepoetin Alfa in Hemodialysis Patients With Chronic Kidney Disease: French Monocentre Observational StudyBinaut, R. / Bacri, J. L. / Fleury, D. / Maisonneuve, N. / Labatut, D. / Lemaitre, V. / Medeghri, Z. / Bir, G. / Lanier, J. et al. | 2012
- A459
-
PRM1 Kaplan-Meier Survival Curves: A Potential Source of Data for Systematic ReviewsGupta, J. / Bhutani, M. K. / Kumar, R. / Kaur, M. / Jindal, R. / Siddiqui, M. K. et al. | 2012
- A460
-
PRM6 The UK Contribution to Real World Research: Review of Published Data at ISPOR, Madrid 2011Peperell, K. / Lones, R. / Devlin, N. et al. | 2012
- A461
-
PRM11 Real-World Data to Calculate Cost-Effectiveness of Monoclonal Antibodies: Problems and Solutionsvan Rooijen, E. M. / van der Linden, N. / van Gils, C. / Oppe, M. / Uyl-de Groot, C. et al. | 2012
- A462
-
PRM16 Access to Cost Data Capture Using Public Database, Website and Literature in Germany, France, Spain and USAAlvarez-Ossorio, L. / Ezzat, N. / Cariou, Y. / Tarab, A. et al. | 2012
- A463
-
PRM22 The Headroom Method of Early Economic Evaluation of Medical Devices: A Useful Tool for Device Developers?Chapman, A. M. / Taylor, C. A. / Girling, A. J. et al. | 2012
- A464
-
PRM27 Evaluating European Data Sources for Assessing Real-World Effectiveness of New Anti-Diabetic DrugsMoï / se, P. / Andreykiv, M. / van Engen, A. / Wimbush, A. J. / Richards, A. / Ploug, U. J. et al. | 2012
- A465
-
PRM33 Real World Evidence: Promise and Pitfalls of Real World DataWeir, S. / Langham, S. / Ratcliffe, M. et al. | 2012
- A466
-
PRM38 Estimation of a Markov Chain for Crohn's Disease and Classification of Patients Into Disease Phenotypes, in Eight Countries Using Individual Longitudinal Data Aggregated Over TimeBorg, S. / Gerdtham, U. G. / Rydé / n, T. / Munkholm, P. / Odes, S. / Langholz, E. / Moum, B. / Annese, V. / Bagnoli, S. et al. | 2012
- A467
-
PRM43 A Systematic Review on the Application of Cardiovascular Risk Prediction Models in Pharmacoeconomics, With a Focus on Primary PreventionStevanovic, J. / Postma, M. J. / Pechlivanoglou, P. et al. | 2012
- A468
-
PRM48 The Half-Cycle “Correction”: How Much of a Correction is it?Taylor, M. / Lewis, L. et al. | 2012
- A469
-
PRM54 Correlating Cost Effectiveness Output With Patient Level Data Input via the IMS Core Diabetes Model (CDM)McEwan, P. / Foos, V. / Lloyd, A. / Palmer, J. L. / Lamotte, M. / Grant, D. et al. | 2012
- A470
-
PRM59 Methods for Discounting in Economic Evaluation; An Empirical Comparison of Preferences in Money and Quality of LifeParouty, M. / Krooshof, D. / Westra, T. / Postma, M. et al. | 2012
- A471
-
PRM65 A Minimal Information Decision-Analytic Approach to Early HTA of Diagnostic TestsKoffijberg, H. / Moons, K. G. / de Wit, G. A. et al. | 2012
- A472
-
PRM70 What If All Other Things are Not Equal? – Accounting for Future Changes in the Decision Context When Extrapolating Cost-Effectiveness Results Over TimeAsaria, M. / Palmer, S. et al. | 2012
- A473
-
PRM75 Parallel Sets as Interactive Visualization Approach for Analyzing Markov ModelsUrach, C. / Piringer, H. / Popper, N. / Breitenecker, F. et al. | 2012
- A475
-
PRM86 Utilizing Indirect Treatment Comparisons in Metastatic Castration Resistant Prostate Cancer (mCRPC)Wasiak, R. / Joulain, F. / Lambrelli, D. / Trask, P. C. / Sartor, O. et al. | 2012
- A476
-
PRM91 How Do Patients With Different Conditions Describe Their Pain?Martin, M. L. / Scanlon, M. / McCarrier, K. P. / Wolfe, M. / Bushnell, D. M. et al. | 2012
- A477
-
PRM96 Reliability of a Patient-Reported Adverse Drug Event Questionnairede Vries, S. T. / de Zeeuw, D. / Haaijer-Ruskamp, F. M. / Denig, P. et al. | 2012
- A478
-
PRM101 A Think Aloud Study Comparing the Validity and Acceptability of Discrete Choice and Best Worst Scaling MethodsWhitty, J. A. / Walker, R. / Golenko, X. / Ratcliffe, J. et al. | 2012
- A479
-
PRM106 Examination of Preferences Elicited From the General Public: Comparisons of Results From the Time Trade-Off and Standard Gamble InstrumentsIskedjian, M. / Navarro, V. / Farah, B. / Berbari, J. / Walker, J. H. / Lelorier, J. et al. | 2012
- A480
-
PRM111 Pediatric Patient-Reported Outcomes Assessment: A Case Study in Epidermolysis BullosaMordin, M. / Clark, M. / Doward, L. / Willian, M. K. et al. | 2012
- A481
-
PRM116 Payer and Patient Perceptions of Medication Value and the Role of Patient-Reported OutcomesCascade, E. / Andreykiv, M. / Istas, A. et al. | 2012
- A482
-
PRM122 Atopic Dermatitis on Families: Creation of a Specific Burden QuestionnaireMeni, C. / Bodemer, C. / Toulon, A. / Branchoux, S. / Taieb, C. et al. | 2012
- A483
-
PRM128 Development of a Translation Evidence Tracking Tool to Comply With the FDA Review Requirements for the Translation of PRO InstrumentsMear, I. / Anfray, C. / Conway, K. et al. | 2012
- A484
-
PRM134 Regression Methods for Health-Related Quality of Life Data in Longitudinal Settings: Are More Advanced Techniques Really Performing Better?Hunger, M. / Dö / ring, A. / Holle, R. et al. | 2012
- A485
-
PRM139 Including Patients in Multiple Groups and Multiple Times in the Same Group in Longitudinal Observational Research: A Cystic Fibrosis ExamplePasta, D. J. / Millar, S. J. et al. | 2012
- A486
-
PRM144 Cardiologists' Knowledge and Awareness of Guidelines for Medical Device Safety and Product Risk ManagementBozkurt, R. / Yildirim, J. et al. | 2012
- A487
-
PRM150 Latent Transition Analysis as a Tool for Analysing Clinical DataMayer, D. / Burgess, A. J. et al. | 2012
- A488
-
PRM155 A Pragmatic Randomized Clinical Trials – Design and Quality Assessment of the Source of Effectiveness DataKaczynski, L. / Solnica, B. et al. | 2012
- A489
-
PRM160 A New Value-Based Pricing Framework for the Optimal Pricing of Pharmaceutical AssetsHawryluk, E. A. / Malhotra, M. / Chawla, V. / Doyle, J. et al. | 2012
- A491
-
PRM171 Optimal Shopping: An Evauation of Decision Rules in Cost-Effectiveness Analysis (CEA)McKenna, C. / Claxton, K. et al. | 2012
- A492
-
PRM177 What is the Role of Early Health Technology Assessment of Biomarkers in the Pre-Clinical Development Phase? A Reflection on Lessons Learned With Multiple MyelomaGaultney, J. G. / Redekop, W. K. / Sonneveld, P. / Uyl-de Groot, C. A. et al. | 2012
- A493
-
PDB4 HbA1C Reduction Associated With Initial Versus Sequential Combination Therapy With Pioglitazone (PIO) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients With Type 2 Diabetes Mellitus (T2DM)Bron, M. / Chen, K. / Ayyagari, R. / Sharma, H. / Wu, E. Q. et al. | 2012
- A494
-
PDB9 Outcome of Fixed Dose Radioactive Iodine for the Treatment of HyperthyroidismObidiya, S. O. / Ogunjobi, K. / Eniojukan, J. F. et al. | 2012
- A495
-
PDB14 Characteristics of the Aboriginal People with Diabetes in the South-Western of Ontario, Canadareza Nakhai-Pour, H. / Tarride, J. E. / Blackhouse, G. / Xie, F. / O'Reilly, D. / Goeree, R. / Petrella, R. J. et al. | 2012
- A496
-
PDB19 A Systematic Review of Recent Data Describing the Risk of Complications in Type 1 Diabetes Mellitus PatientsPearson, I. / Wolowacz, S. / Irving, A. / Brockbank, J. / Chubb, B. / Gundgaard, J. / Briggs, A. / Davies, M. J. et al. | 2012
- A497
-
PDB25 Evaluation of Health Care Cost of Diabetes Before and After Counseling in South Indian Community SetupMateti, U. V. / Akari, S. / Adla, N. et al. | 2012
- A498
-
PDB30 The Pattern and Prescription Cost Among Diabetic Patients in the HO Municipal Hospital, Volta Region, GhanaOkotah, A. N. et al. | 2012
- A499
-
PDB35 Evaluation of the Long Term Economic Impact of Improving Hba1C in Type 2 Diabetes Patients in Saudi ArabiaTodorova, L. / Baabbad, R. / Smith-palmer, J. / Al-mansari, A. et al. | 2012
- A500
-
PDB41 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in AlgeriaRoca, P. / Lamri, L. / Belhadj, M. / Pollock, R. F. / Valentine, W. J. / Todorova, L. et al. | 2012
- A501
-
PDB46 Anti-Diabetic Drugs and In-Patient Admissions Attributable to Diabetes in PortugalGouveia, M. / Laires, P. / Borges, M. / Augusto, M. / Martins, A. P. et al. | 2012
- A502
-
PDB51 Resource Utilization in the Management of Acromegaly: An Analysis From Southwest OntarioPetrella, R. J. / Van uum, S. / Hurry, M. et al. | 2012
- A503
-
PDB56 Development and Validation of Patient Reported Endpoints for T2DMBron, M. / Hudgens, S. / Stokes, J. / Banderas, B. / Viswanathan, P. / Dabbous, O. et al. | 2012
- A504
-
PDB61 Research on the Incidence and Cost of Hypoglycemia Episode in Patients With Type 2 Diabetes Mellitus (T2DM)Zheng, Y. / Wu, J. / sterle, A. et al. | 2012
- A506
-
PDB73 Obesity and Frequent Hypoglycemia in European Type 2 Diabetes PatientsVietri, J. / Isherwood, G. / Le pautremat, V. / Eschwè / ge, E. M. et al. | 2012
- A507
-
PDB78 Determinants of Treatment Changes of Oral Anti/Diabetic Drugs in the UKMaguire, A. / Mitchell, B. et al. | 2012
- A508
-
PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Comparative Effectiveness Analysis Using Indirect Statistical TechniquesKaura, S. / Dranitsaris, G. et al. | 2012
- A509
-
PSY10 An Indirect Comparison of Icatibant and Four Other Therapies for the Symptomatic Treatment of Acute Attacks of Hereditary Angioedema Types I and IIHelbert, M. / Pang, F. / Alvarez-Reyes, M. / Roskell, N. S. / Diwakar, L. et al. | 2012
- A510
-
PSY15 Impact of Chronic Immune-Mediated Inflammatory Diseases on Work Productivity: Literature ReviewGranados, D. / Depont, F. / Chevreul, K. et al. | 2012
- A511
-
PSY20 Cost-Effectiveness of Prophylaxis With an Anti-Inhibitor Complex Concentrate in Patients With Haemophilia and Inhibitors: Results From Pro-Feiba StudyGringeri, A. / Leissinger, C. / Cortesi, P. A. / Cristiani, M. / Fusco, F. / Mantovani, L. G. et al. | 2012
- A512
-
PSY25 Etanercept in Early Rheumatoid Arthritis: Economic Evaluation From the Public Payer Perspective in BrazilTakemoto, M. / Fernandes, R. A. / Fujii, R. K. / Mould, J. / Tang, B. et al. | 2012
- A514
-
PSY35 Assessment of the Most Bothersome Symptoms and Impacts Reported by Patients With Chronic Low Back PainRamasamy, A. / Blum, S. I. / Liedgens, H. / Martin, M. L. / McCarrier, K. P. / Quintanar-Solares, M. / Argoff, C. / Freynhagen, R. / Patrick, D. L. / Wallace, M. S. et al. | 2012
- A515
-
PSY40 Health-Related Quality of Life and Annual Direct Medical Cost of Patients With Haemophilia B in France: The EQOFIX StudyPolack, B. / Calvez, T. / Claeyssens, S. / Chambost, H. / Derlon, A. / Goudemand, J. / Rothschild, C. / Maurel, F. / Woronoff-Lemsi, M. C. et al. | 2012
- A516
-
PSY45 Social Economic Burden and Health-Related Quality of Life in Patients With Rare Diseases in Europe (BURQOL-RD Project). Spanish ResultsLinertová / R. / Ló / pez-Bastida, J. / Serrano-Aguilar, P. / Posada-de-la-Paz, M. et al. | 2012
- A517
-
PHS1 The Effect of Positioning and PNF-Exercise to Postoperative Bleeding After Hip ReplacementGombos, G. / Steinhausz, V. / Bajsz, V. / Sió / E. / Turcsanyi, K. / Molics, B. / Boncz, I. / Schmidt, B. et al. | 2012
- A519
-
PHS12 Meta-Analysis of Parkinson's Disease Risk With Hypertension, Serum Total Cholesterol, and Diabetes MellitusMounika, P. / Venkat, A. / Chaitanya, P. / Dev, K. et al. | 2012
- A520
-
PHS17 Costs of Influenza A(H1N1)2009 Infection During the Pandemic and the Postpandemic-Seasonal WavesGarin, O. / Galante, M. / Hollmann, M. / Sicuri, E. / Cots, F. / Garcia-Alté / s, A. / Ferrer, M. / Dominguez, x. / Castilla, J. et al. | 2012
- A521
-
PHS22 Burden of Invasive Pneumococcal Diseases in Older Adults in the New EU Countries of the Central EuropeTichopad, A. / Roberts, C. S. / Skoczynska, A. / Hryniewitz, W. / Gembula, I. / Hajek, P. / Krizova, P. / Motlova, J. / Avdicova, M. et al. | 2012
- A522
-
PHS28 The Cost of Management of Patients With Atrial Fibrillation : An Observational Study in UK NHS Primary CareKassianos, G. / Fuat, A. / Arden, C. D. / Hogan, S. / Baldock, L. et al. | 2012
- A523
-
PHS33 Cost Analysis of Dialysis Practice in TurkeyTatar, M. / Ergin oguzhan, G. / Kockaya, G. et al. | 2012
- A524
-
PHS39 Cost-Effectiveness of a Nurse-Led Integrated Chronic Care Approach Versus Usual Care in Patients With Atrial FibrillationHendriks, J. M. / Tomini, F. / Van asselt, A. D. et al. | 2012
- A525
-
PHS44 Economic Evaluation of Universal Hepatitis B Vaccination Strategy in JapanHirao, T. / Sato, T. / Sugimori, H. / Suka, M. / Yoda, T. / Yoshioka, A. / Akazawa, M. / Igarashi, A. / Kobayashi, M. / Ikeda, S. et al. | 2012
- A526
-
PHS49 Cost of Hypoglycaemia in Patients With Diabetes in PolandWidz, K. / Czech, M. / Hermanowski, T. et al. | 2012
- A527
-
PHS54 Use of Health Care Administrative Databases to Estimate the Health Care Burden of Bone or Bone Marrow Metastatic Deases in Breast Cancer Patients: A Population-Based StudyMantovani, L. G. / Scalone, L. / Furneri, G. / Ciampichini, R. / Cortesi, P. A. / Fornari, C. / Madotto, F. / Chiodini, V. / Cesana, G. et al. | 2012
- A528
-
PHS60 Health-Related Quality of Life in HIV/HCV Co-Infected Patients in IrelandMcgreal-bellone, A. / Cleary, S. / Farrell, G. / Bergin, C. / Barry, M. / Kieran, J. et al. | 2012
- A529
-
PHS65 Mapping the Disease-Specific FACT-P to the Preference-Based EQ-5D in Castration-Resistant Prostate CancerIvanescu, C. / Skaltsa, K. / Holmstrom, S. et al. | 2012
- A530
-
PHS70 Health Related Quality of Life As Predictor of Death Among Patients With Heart FailureEscobar, A. / Bilbao, A. / Gonzalez-Saenz de Tejada, M. / Fernandez-soto, M. / Lafuente, I. / Sanchez-haya, E. / Citores, L. et al. | 2012
- A531
-
PHS76 An Infuenza Vaccination Policy Based on a Previous Year's IllnessYamin, D. / Gavious, A. / Solnik, E. / Davidovitch, N. / Pliskin, J. S. et al. | 2012
- A532
-
PHS81 Health Care Organizations/Services Clustering: Comparison of Several Techniques Using UK DataMillier, A. / Mejri, S. / Aballea, S. / Toumi, M. et al. | 2012
- A533
-
PHS87 Cost of Diabetes in Insulin-Treated Patients in BulgariaDoneva, M. / Valov, V. / Borissova, A. M. / Tankova, T. / Savova, A. / Manova, M. / Petrova, G. / Czech, M. et al. | 2012
- A534
-
PHS93 HbA1c Test Utilization Among Hospitalized Patients With HyperglycemiaEby, E. / Gelwicks, S. / Marchlowska, P. A. et al. | 2012
- A535
-
PHS98 Clinical Characteristics, Treatment Patterns, and Resource Utilization in a Real-World European Population With DiverticulitisDavis, K. L. / Mitra, D. / Yen, L. et al. | 2012
- A536
-
PIH5 Preventable Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities - A Systematic-ReviewWilbur, K. / Hazi, H. / El-Badawi, A. et al. | 2012
- A538
-
PIH16 Epidemiology of Herpes Zoster and Its Related Resource Utilization: A Large Population-Based Study in IsraelWeitzman, D. / Shavit, O. / Stein, M. / Shay, N. / Cohen, R. / Chodick, G. / Shalev, V. et al. | 2012
- A539
-
PIH22 Clinical Efficacy and Cost-Effectiveness of Human Recombinant Interferon-α2B in Neonatal InfectionsSoldatova, I. / Pankratyeva, L. et al. | 2012
- A540
-
PIH27 Cost Analysis of Neonatal and Pediatric Parenteral Nutrition in BelgiumWalter, E. / Dragosits, A. / Noerens, K. / De Bosscher, H. / Blom, H. / Maton, P. et al. | 2012
- A541
-
PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a ProblemPumford, N. / Muston, D. / Wade, A. / Crawford, G. / Young, D. et al. | 2012
- A542
-
PIH37 Trends of Quality of Life in South Korean Adults During 2007-2010Chang, C. W. / Choi, I. S. / Lee, S. M. / Suh, D. C. et al. | 2012
- A543
-
PIH43 Comparison of Unintended Pregnancy Rates Among Women Who Initiated Oral Contraceptive Therapy with a 84/7 Estradiol or a 84/7 PlaceboBrewster, C. / Lage, M. J. / Grubb, E. et al. | 2012
- A544
-
PIH48 Service Uses and Costs of Child and Adolescent Psychiatric Patients Treated with Antipsychotics in TaiwanChang, H. C. / Mccrone, P. / Su, K. P. et al. | 2012
- A545
-
PND2 Effect of Cognitive Behavioural Therapy in Multiple Sclerosis Fatigue: A Systematic Review of Randomised Controlled TrialsKohli, I. S. / Kataria, A. / Singla, S. / Kaushik, P. / Jindal, R. / Aggarwal, A. et al. | 2012
- A546
-
PND7 Off-Label Use of Antiepileptic Drugs and its Costs – a Drug Utilization Study in PortugalAfonso-Silva, M. / Oliveira-Martins, S. / Cabrita, J. et al. | 2012
- A547
-
PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic EncephalopathyCardona, D. P. / Zapata, L. / Ceballos, M. / Diez, F. / Rico, I. / Zavala, A. et al. | 2012
- A548
-
PND18 Impact of Co-Morbidities on the Economic Burden of Parkinson'S Disease in Germany Post-2000Takyar, S. / Kataria, A. / Rajput, A. / Kaur, M. et al. | 2012
- A550
-
PND29 Cost Evaluation of Multiple Sclerosis at Different Stages in IranKhanizadeh, H. et al. | 2012
- A552
-
PND40 Cost-Utility Analysis of Fingolimod in Brazilian Patients With Multiple SclerosisSilva, N. L. / Takemoto, M. L. / Cruz, R. B. / Suzuki, C. et al. | 2012
- A553
-
PND45 Differential Outcomes in Patients With Alzheimer'S Disease (AD) Treated With Donepezil 23Copher, R. / Li, X. / Powers, A. / Clionsky, E. et al. | 2012
- A554
-
PND50 Estimation of the Effect of Dalfampridine Extended Release on Health Utility in Patients With Multiple Sclerosis Using Two Equations for Mapping the MSWS-12 to the EQ-5DLimone, B. / Sidovar, M. / Gaebler, J. A. / Lee, S. / Coleman, C. I. et al. | 2012
- A556
-
PND60 Non-Diabetic Peripheral Neuropathic Pain is Underdiagnosed in GP Practices Although it has High Impact on Patients' Health Related Quality of LifeBrodszky, V. / Komoly, S. / Bereczki, D. / Embey-Isztin, D. / Gulá / csi, L. / Balogh, O. / V. Hevé / r, N. / Torzsa, P. et al. | 2012
- A557
-
PND66 Therapeutic Equivalence as a Means of Improving the Efficiency in the Treatment of Multiple SclerosisBautista Paloma, F. J. / Flores Moreno, S. / Ucles Sanchez, A. / Casado Chocan, J. / Jimenez Hernandez, D. et al. | 2012
- A558
-
PND71 Predictors of Treatment Class Choice in Parkinson's DiseaseGrubb, E. / Castelli-Haley, J. / Treglia, M. / Lage, M. J. et al. | 2012
- A559
-
PRS2 A Retrospective Epidemiologic Review of COPD in KoreaJoo, H. / Jung, K. S. / Jeung, J. et al. | 2012
- A560
-
PRS8 Burden of Exacerbations in Patients With COPD in the Netherlands: a Real-Life StudyOverbeek, J. A. / Balp, M. M. / Penning, F. J. / Dekhuijzen, P. N. / Herings, R. M. et al. | 2012
- A561
-
PRS14 Clinical and Pharmacoeconomic Aspects of Allergen Immunotherapy in the Slovak RepublicBielik, J. / Pruzinec, P. / Tor, P. et al. | 2012
- A562
-
PRS20 Cost-Benefit Analysis for a Treatment of Pulmonary Arterial HypertensionIskedjian, M. / Walker, J. H. / McLean, A. / Farah, B. / Berbari, J. / Watson, J. A. et al. | 2012
- A563
-
PRS25 Cost Analysis of Omalizumab Use in Patients With Severe Uncontrolled Asthma Within the Mexican Public Health Care SystemLemus-Carmona, E. / Reyes-Lopez, A. / Jimenez Aranda, P. et al. | 2012
- A564
-
PRS30 Cost-Effectiveness Analysis of 100% Whey-Based Partially Hydrolyzed Infant Formula Used for Prevention of Atopic Dermatitis in GermanyErdogan Ciftci, E. / Horodniceanu, E. G. / Botteman, M. F. / Detzel, P. / Verheggen, B. G. et al. | 2012
- A565
-
PRS35 The Economic Burden of HAE: Findings From the HAE Burden of Illness Study in Europe (HAE-BOIS-Europe)Aygö / ren-Pü / rsü / n, E. / Bygum, A. / Caballero, T. / Beusterien, K. / Hautamaki, E. / Musingarimi, P. / Wait, S. et al. | 2012
- A566
-
PRS41 Characteristics and Determinants of Palivizumab Use in the NetherlandsHouweling, L. M. / Penning-van Beest, F. J. / Bezemer, I. D. / van Lingen, R. A. / Herings, R. M. et al. | 2012
- A567
-
PRS46 Health Care Resource Use of Patients With Cystic Fibrosis (CF) in the UKLambrelli, D. / Wasiak, R. / Ingram, A. / Harrow, B. / Becker, C. / Eriksson, D. / Wyatt, H. et al. | 2012
- A569
-
PSS10 Economical Burden of Severe Visual Impairment and Blindness – a Systematic ReviewKö / berlein, J. / Beifus, K. / Finger, R. et al. | 2012
- A570
-
PSS15 A New Insight Into Cost-Effectiveness Analyses in Atopic Dermatitis: The Tacrolimus 0.1% Ointment Versus Ciclosporin ComparisonAlmeida, J. / Vandewalle, B. / Silva, M. J. / Fé / lix, J. et al. | 2012
- A571
-
PSS20 Cost-Utility Analysis of Treatments for Macular Edema Secondary to Retinal Vein OcclusionDuff, S. / Gricar, J. / Kymes, S. / Tran, I. / Turpcu, A. / Sternberg, G. et al. | 2012
- A572
-
PSS25 Validation of the Patient Benefit Index (PBI) for the Assessment of Patient-Defined Benefit in the Treatment of PsoriasisFeuerhahn, J. / Blome, C. / Radtke, M. A. / Augustin, M. et al. | 2012
- A576
-
ISPOR 15th Annual European Congress Disclosure Information for Research Presentations| 2012
- A587
-
ISPOR 15th Annual European Congress Research Abstracts Author Index| 2012
- A602
-
CN1 Statins and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus InfectionTsan, Y. / Lee, C. / Wang, J. / Chen, P. et al. | 2012
- A603
-
DB2 Vitamin D Deficiency and Diabetes: Perceptions of Pharmacists and PhysiciansJalundhwala, F. / Majumdar, A. / Malthankar, S. / Jalundhwala, Y. et al. | 2012
- A604
-
HC3 The Process of Updating the Items of National Health Insurance Benefits Schedule in Taiwan: is It Fair and Legitimate?Lin, C. W. et al. | 2012
- A605
-
ME4 Using Discrete Choice Experiments to Value Health States for Economic Evaluation – the SF-6D in AustraliaNorman, R. / Viney, R. / Brazier, J. / Burgess, L. / Cronin, P. / King, M. / Ratcliffe, J. / Street, D. J. et al. | 2012
- A607
-
EX3 A Evaluation of the Effects from China Drug Policy Reform During 2009-2011: Some Success, Many Unintended EffectsGuan, Q. / Cai, J. / Dummett, H. / Tan, S. C. et al. | 2012
- A608
-
PR1 Does Medication Adherence Correlate With Health-Related Quality of Life? Findings From a Descriptive AnalysisSaleem, F. / Hassali, M. A. / Shafie, A. A. / Aljadhey, H. / Haq, N. / Atif, M. et al. | 2012
- A610
-
PHP8 Factors Associated with Unnecessary Use of Antibiotics in U.S. State Medicaid ProgramsLi, P. / Marcus, S. / Metlay, J. / Doshi, J. A. et al. | 2012
- A611
-
PHP14 The Implementation of Essential Medicine Policy in China: Pros and ConsHu, S. / Zhang, Y. / He, J. J. et al. | 2012
- A613
-
PHP25 Market Analysis of Antibiotics Consumption in Northern Part of Iran During 2001-2010Zaboli, P. / Ala, S. / Kebriaee Zadeh, A. / Abdollahiasl, A. / Nikfar, S. et al. | 2012
- A614
-
PHP30 The Utilization and Expenditure of Reimbursed Digestive Enzyme Agents in TaiwanYang, W. W. / Wang, Y. C. / Pwu, R. F. et al. | 2012
- A615
-
PHP36 Comparing Oral 5-Aminosalicylic Acid Treatment Persistence and Adherence in Patients with Ulcerative Colitis in the United StatesYen, L. / Wu, J. / Hodgkins, P. / Nichol, M. B. et al. | 2012
- A616
-
PHP41 Risk Management in Iranian Pharmaceutical Companies to Ensure Accessibility and Quality of MedicinesJaberidoost, M. / Abdollahiasl, A. / Farshchi, A. / Dinarvand, R. et al. | 2012
- A617
-
PHP47 Impact of Economic and Policy Factors on China'S Health Care ExpenditureZhang, J. / Ando, G. / Bharath, A. et al. | 2012
- A618
-
PHP53 Comparative Evaluation of Drug Information Sources Used by DoctorsKini, S. / Ankush, C. / Pratik, G. / Shahank, W. / Ligade, V. S. / Sreedhar, D. / Udupa, N. et al. | 2012
- A619
-
PHP60 Iranian Pharmacists' Job Satisfaction: Analysis Through Various Job CharacteristicsForoughi Moghadam, M. J. / Peiravian, F. / Naderi, A. / Mehralian, G. / Rasekh, H. et al. | 2012
- A621
-
PHP76 Evidence Requirements for Pricing and Reimbursement Decision Making for Orphan Drugs in AsiaTan, S. / Dummett, H. / Kirpekar, S. / Guan, Q. / Priest, V. L. et al. | 2012
- A622
-
PHP81 Factors Influencing Interprofessional Collaboration: A Literature Review from 2004-2011Chang, E. H. / Doucette, W. R. et al. | 2012
- A623
-
PHP87 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in ShenyangZhang, F. / Li, S. C. / Du, J. et al. | 2012
- A625
-
PHP99 Implementation of a Formulary Management Programme in SingaporeZhao, Y. J. / Teng, M. / Khoo, A. L. / Lim, B. P. et al. | 2012
- A626
-
PHP108 Pattern of Antibiotics Usage in Malaysian Hajj PilgrimAbd Aziz, N. / Hassan, Y. / Hashim, H. / Malik Mansoor, S. / Abd Shatar, A. K. et al. | 2012
- A627
-
PHP113 Utilization of FPG, HbA1C and Self-Monitoring of Blood Glucose (SMBG) in Community Health Centers in the Shanghai AreaMast, O. / Tan, A. et al. | 2012
- A628
-
PHP118 The Attitude of Farmers to the New Rural Cooperative Medical Scheme in the Northwest of China: A Cross-Sectional StudyXu, C. / Gericke, C. A. et al. | 2012
- A629
-
PCV5 The Effeects of Statins on Blood Presure in Normotensive or Hypertensive Subjects-a Meta-Analysis of 18 Randomized Controlled Trials Involving 5628 ParticipantsBanach, M. / Nikfar, S. / Rahimi, R. / Mikhailidis, D. P. / Narkiewicz, K. / Rysz, J. / Abdollahi, M. et al. | 2012
- A630
-
PCV11 Use of Anti-Infectives for Systemic Administration in Serbia in 2010Milijasevic, B. / Tomic, Z. / Sabo, A. / Vukmirovic, S. et al. | 2012
- A631
-
PCV19 Hospitalization Costs and Their Predictors in Patients With Venous Thromboembolism in ChinaWu, J. / Yang, L. / Zhu, G. et al. | 2012
- A632
-
PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial: A Singapore Health Care PerspectiveChin, C. T. / Mellströ / m, C. / Chua, T. S. / Matchar, D. B. et al. | 2012
- A633
-
PCV31 Cost-Effectiveness of Apixaban Versus Enoxaparin for the Prevention of Postsurgical Venous Thromboembolism in KoreaOh, J. J. / Shin, H. H. / Jung, H. / Park, J. H. / Ko, S. K. et al. | 2012
- A634
-
PCV36 Validation 36 and Comparison of the SF-6D and EQ-5D in Chinese Patients With Stable Angina PectorisWu, J. / Han, Y. / Gao, Y. / Zhou, J. / Chen, Z. / Sun, H. et al. | 2012
- A635
-
PGI5 Increasing Demands for Medical and Drug Utilization in Patients With Long-Term Irritable Bowel Syndrome in TaiwanHsu, C. C. / Chen, L. C. / Wen, Y. H. et al. | 2012
- A636
-
PGI10 Factors Associated With Treatment Adherence and Persistence in Canadian Patients With Ulcerative Colitis (Uc): Analysis of Prescription Claims From the Ramq DatabaseLachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. et al. | 2012
- A637
-
PGI16 Treatment With Prucalopride for Chronic Constipation Improves the Symptoms and Quality of Life of Patients in ChinaKe, M. Y. / Zou, D. W. / Yuan, Y. Z. / Li, Y. Q. / Lin, L. / Ji, J. / Song, W. J. / Du, X. X. / Chang, J. H. et al. | 2012
- A638
-
PIH6 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Exploring Impacts of Herd Immunity and Patterns of BreastfeedingofTu, H. A. / Coyte, P. / Li, S. C. / Postma, M. J. et al. | 2012
- A639
-
PIH12 A Descriptive Study of Health Related Quality of Life among General Population of Quetta, PakistanUl Haq, N. / Hassali, M. A. / Shafie, A. A. / Saleem, F. / Aljadhey, H. / Atif, M. / Iqbal, Q. et al. | 2012
- A640
-
PRS6 Self-Reported Adherence to Inhaled Corticosteroids and Beliefs About Medicines in Asthma Patients: A Study From Emergency Room of a Chest Hospital in Delhi, IndiaKotwani, A. / Shendge, S. et al. | 2012
- A641
-
PRS11 Assessment of Knowledge About Tuberculosis Among Libyan and Non Libyan Populations in North East LibyaSolliman, M. M. / Hassali, M. A. / Al-Haddad, M. S. / Atif, M. / Shafie, A. A. / Saleem, F. / Aljadhey, H. / Haq, N. et al. | 2012
- A642
-
PSS3 Medical Resource Use and Associated Costs in Open-Angle Glaucoma in 10 Asia-Pacific CountriesGerlier, L. / Lamotte, M. / Caputo, J. / Tan, R. et al. | 2012
- A643
-
PSS8 Health Burden of Vision Problems in Asia: A Study of Malays and Indians in SingaporeWang, X. / Ang, M. / Chiang, P. / Zheng, Y. / Cheng, C. Y. / Lamoureux, E. / Wong, T. Y. / Luo, N. et al. | 2012
- A644
-
PUK5 Clinical and Economic Impacts of Clinical Pharmacy Education on Infection Management Among Patents With Chronic Kidney Disease in a Hospital (Indonesia)Nasution, A. / Syed Sulaiman, S. A. / Shafie, A. A. et al. | 2012
- A645
-
PRM4 QALY and Productivity Loss: Empirical Evidence for “Double Counting”Shiroiwa, T. / Fukuda, T. / Shimozuma, K. / Ikeda, S. et al. | 2012
- A646
-
PRM11 Evidence for Validity of a National Patient-Reported Survey in Japan: The Japan National Health and Wellness SurveyDibonaventura, M. D. / Fukuda, T. / Stankus, A. et al. | 2012
- A647
-
PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov ModelJahn, B. / Rochau, U. / Arvandi, M. / Kuehne, F. / Kluibenschaedl, M. / Paulden, M. / Krahn, M. / Siebert, U. et al. | 2012
- A648
-
PRM21 Validity and Reliability of the 8-Item Morisky Medication Adherence Scale in Patients Taking Warfarin in SingaporeWang, Y. / Kong, M. C. / Ko, Y. et al. | 2012
- A650
-
PRM32 Reliability and Validity of an Instrument Used in a Tobacco Cessation Intervention Study Among Patients With DiabetesIbrahim, K. A. / Syed sulaiman, S. A. / Shafie, A. A. / Awaisu, A. / Lajis, R. / Nasution, A. et al. | 2012
- A652
-
PRM44 Clinical and Comparative Economic Value - A Novel Pharmacoeconomic Analysis Embedded in the Drug Development ProcessFang, X. / Seo, M. / Standing, M. / Xu, Z. / Jacobson, S. / Woolmore, A. et al. | 2012
- A653
-
PCN5 Impact of Erythropoiesis Stimulating Agents on Survival among Patinets With Colorectal Cancer Receiving ChemotherapySato, M. / Freedman, A. / Trovato, J. / Zhan, M. / Cunningham, F. / Weiss Smith, S. et al. | 2012
- A654
-
PCN10 Risk of Breast Cancer and Statins: A Population-Based Nested Case-Control Study in Chinese PopulationChan, A. L. / Leung, H. W. / Wang, J. J. et al. | 2012
- A655
-
PCN16 Comparison of the Efficacy and Cost of Novel Targeted Cancer TherapiesKaura, S. / Khan, Z. et al. | 2012
- A656
-
PCN22 Cost-Effectiveness Analysis of Cervical Cancer Screening With Self-Sampling for Human Papillomavirus (HPV) Testing in TaiwanTsai, B. C. / Chow, I. H. / Liao, C. H. / You, S. L. / Tang, C. H. / Pwu, R. F. et al. | 2012
- A657
-
PCN27 Disclosing Complementary and Alternative Medicines (CAM) Use to the Health Care Providers:A Descriptive StudyFarooqui, M. / Hassali, M. A. / Knight, A. / Akmal, A. / Farooqui, M. A. / Seang, T. B. et al. | 2012
- A659
-
PDB5 Statin is a Reasonable Treatment Option for Patients With Polysystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled TrialsGao, L. / Li, S. C. et al. | 2012
- A660
-
PDB12 Role of Chromium in Type-2 Diabetes Therapy: A Systematic Review StudyFarshchi, A. / Seyedifar, M. / Abdollahiasl, A. / Nikfar, S. / Jaberidoost, M. / Esteghamati, A. / Abdollahi, M. et al. | 2012
- A661
-
PDB17 Comparison of Clinical and Economic Outcomes Associated With Dpp4 Inhibitors (DPP4I) Versus Sulfonylurea (SU) in Combination with Metformin (MET) or Pioglitazone (PIO) for the Treatment of Type 2 Diabetes Mellitus (T2DM)Bron, M. / Chen, K. / Cheng, D. / Bensimon, A. G. / Wu, E. Q. et al. | 2012
- A662
-
PDB22 The Direct Medical Cost for Diabetes Mellitus (DM) Related Complications in ChinaZheng, Y. / sterle, A. / Liu, X. / Wu, J. et al. | 2012
- A664
-
PDB33 Physician'S and Patient'S Perceptions and Beliefs Regarding Insulin Initiation and Use in Patients With Type 2 Diabetes (T2DM) in ChinaLiu, L. L. / Babineaux, S. M. / Kadziola, Z. / Brnabic, A. J. / Luo, T. et al. | 2012
- A665
-
PIN2 Assessing the Diagnostic Performance of Human Immunodeficiency Virus Type 1 (HIV-1) Tropism Testing Methods: A Systematic Review of Genotypic Sequencing of the Third Hypervariable (V3) Loop and Enhanced-Sensitivity Phenotypic Assay TechnologyNeedham, M. O. / Paech, D. / Norris, S. / Campbell, S. et al. | 2012
- A666
-
PIN7 Estimate of Infectious Disease Burden Attributable to Climate ChangePathak, P. / Rana, C. et al. | 2012
- A667
-
PIN13 Cost of Antibiotics Used for Nosocromaial Infection Treatment in Inpatient Department at Nakhon Pathom HospitalTewthanom, K. et al. | 2012
- A669
-
PMH6 Factors Associated with Medical Expenditure for Dementia in South KoreaJang, S. / Lee, T. J. / Yu, S. Y. et al. | 2012
- A670
-
PMH12 Medication Adherence, Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia Receiving Oral Hypoglycemic TherapyCheng, J. S. / Shih, Y. T. et al. | 2012
- A671
-
PMS5 A Randomized, Placebo Controlled Trial to Compare Safety and Efficacy Between Curcuma Longa Linn Extract [NR-INF-02], Glucosamine Sulphate and Combination of Two in the Treatment of Painful Knee OsteoarthritisKulkarni, C. / Madhu, K. / Saji, M. et al. | 2012
- A672
-
PMS12 Cost Implication of Prescriptions in Private and Public Health Institutions in Bayelsa State of NigeriaEniojukan, J. F. / Orumwense, D. O. / Obidiya, S. O. et al. | 2012
- A673
-
PMS17 Burden of Ankylosing Spondylitis in Urban ChinaTang, B. / Yang, L. / Liu, Y. / Chapnick, J. / Dong, P. / Wu, M. / He, S. et al. | 2012
- A674
-
PMS22 Improvement on Quality of Life and Daily Function in Rheumatoid Arthritis Patients Treated with Infliximab in ChinaHe, D. Y. / Chen, J. W. / Bi, L. Q. / Wu, L. J. / Lin, J. / Wang, N. S. / Li, J. G. / Yue, N. / Feng, W. W. et al. | 2012
- A675
-
PND5 Budget Impact of Oral Prolonged-Release Fampridine for Management of Walking Disability Associated With Multiple Sclerosis in TaiwanLee-Grossman, C. W. / Alexopoulos, S. T. / Murphy, D. R. et al. | 2012
- A676
-
PND11 Lacosamide for the Treatment of Partial Onset Seizures With or Without Secondary Generalisation: Cost-Effectiveness Analysis on Treating Patients With Lacosamide in Combination With a Non-Sodium Anti-Epileptic MedicationMakarounas-Kichmann, K. / Kirchmann, M. / Monin, N. et al. | 2012
- A677
-
PSY1 Burdens of Psoriasis in the Asia Pacific Region: A Literature ReviewSchenkel, B. / Leartsakulpanitch, J. / Yue, N. et al. | 2012
- A678
-
PSY7 Impact of Anti-Viral Treatment on the Economic Burden of Chronic Hepatitis B in TaiwanChen, P. J. / Chen, C. J. / Yang, H. I. / McLeod, E. / Heatley, R. et al. | 2012
- A679
-
PSY13 Systematic Review of the Economic and Epidemiological Burden of Bleeding-Related Complications in Hong KongTan, J. / Standfield, L. / Metz, L. et al. | 2012
- A680
-
PSY19 Access to Care and Health Outcomes Among the Hemophilia A Population in Developing Countries: A Comparison Between Philippines and ColombiaZhang, M. / Ito, D. / Xiong, Y. / Epstein, J. et al. | 2012
- A682
-
ISPOR 5th Asia-Pacific Conference Disclosure Information for Research Presentations| 2012
- A685
-
ISPOR 5TH Asia-Pacific Conference Research Abstracts Author Index| 2012
- i
-
Table of Contents| 2012
- III
-
Instructions for Authors| 2012
-
DB4 Patient-Reported Hypoglycaemia in Real-World Settings in Seven European Countriesstenson, C. G. / Geelhoed-Duijvestijn, P. H. / Jensen, M. M. / Pedersen-Bjergaard, U. et al. | 2012
-
RU1 Cholinesterase Inhibitors: A Population-Based Assessment of Resource Utilization and Costs for Patients With Alzheimer'S DementiaFong, R. K. / Gill, S. S. / Johnson, A. P. et al. | 2012
-
CV4 Evaluation of Telemonitoring for Heart Failure Patients With Implantable Defibrillators: The Evolvo (Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators) StudyZanaboni, P. / Marzegalli, M. / Landolina, M. E. / Lunati, M. / Perego, G. B. / Guenzati, G. / Curnis, A. / Borghetti, F. / Beccagutti, G. / Borghi, G. et al. | 2012
-
PA4 Home Dialysis: How High can we go?Laplante, S. / Rutherford, P. et al. | 2012
-
CA2 Applying a Value-Based Price Across Different Disease AreasWilson, T. / Kusel, J. / Brooks-Rooney, C. / Costello, S. et al. | 2012
-
DU1 A Time Series Analysis of the Effect of the Co-Payment on Pharmaceutical Consumption in Two Italian RegionsSiviero, P. D. / Cangini, A. / Fabrizi, E. et al. | 2012
-
VA2 Correlates of Protection for Vaccines: When Does a Correlate Equal Protection?Desai, K. / Chen, X. / Bailleux, F. / Qin, L. / Dunning, A. et al. | 2012
-
VA3 How Agent-Based Models Reveal the Dynamic of Epidemics – a Case Study on InfluenzaMiksch, F. / Urach, C. / Zauner, G. / Schiller-Frü / hwirth, I. / Endel, G. / Einzinger, P. / Popper, N. et al. | 2012
-
PRM109 Content Validity of a Treatment Satisfaction Questionnaire in Non-Hodgkin's LymphomaCampbell, A. / Wiesner, C. / Garcia, E. B. / Tatlock, S. / Humphrey, L. et al. | 2012
-
PRM131 How Might Experience-Based Utility Measures Influence Reimbursement Decisions?Marsh, K. / Browne, C. et al. | 2012
-
PRM132 Using Clinical Outcome Assessments and Economic Data to Facilitate Patient Access in Rheumatoid ArthritisGater, A. / Kitchen, H. / Heron, L. / Hansen, B. B. / Hø / jbjerre, L. / Strandberg-Larsen, M. et al. | 2012
-
PRM146 An Excel Calculator Tool to Perform Meta-AnalysisBaser, E. / Lewis-Beck, C. / Baser, O. et al. | 2012
-
PRM148 Sample Size and Power Considerations in Network Meta-AnalysisThorlund, K. / Mills, E. et al. | 2012
-
PRM152 Is it Just Semantics? The Use of “Efficacy” and “Effectiveness” in Comparative Effectiveness Reviews and Health Technology AssessmentsJaksa, A. / Rubinstein, E. / Ho, Y. S. / Daniel, K. et al. | 2012
-
PRM173 On the Probability of Intertemporal IndifferenceParouty, M. / Postma, M. et al. | 2012
-
PDB33 Burden of Disease Attributable to Clinical and Subclinical Hypothyroidism in the Spanish PopulationCrespo, C. / Pé / rez-Alcá / ntara, F. / Polanco, C. et al. | 2012
-
PDB62 Type 2 Diabetes in Russia: Prevalence, Risk Factors, and BurdenDibonaventura, M. D. / Kontsevaya, A. / Isherwood, G. et al. | 2012
-
PSY14 Long-Term Medical Costs and Life Expectancy of Acute Myeloid Leukaemia: A Probabilistic Decision ModelWang, H. I. / Howell, D. / Smith, A. / Roman, E. / Aas, E. et al. | 2012
-
PSY21 Cost-Effectiveness of Posaconazole Versus Fluconazole in the Prophylaxis of Invasive Fungal Infections in Patients With Graft-Versus-Host Disease (GVHD) in TurkeyAkan, H. / Ozdemir, O. et al. | 2012
-
PSY28 Cost-Effectiveness of Febuxostat in Managing Hyperuricemia in Gout Patients in SpainCuesta, M. / Pé / rez Alcá / ntara, F. / Brosa, M. et al. | 2012
-
PSY29 Title: The Challenge of Conducting a Prospective Economic Evaluation of a Pharmacogenetic TestThompson, A. / Payne, K. / Roberts, S. A. / Newman, W. / Elliott, R. A. / Tricker, K. et al. | 2012
-
PHS2 Population Risk Stratification: Based on the Cost of Care in Patients With Chronic DiseasesSicras-Mainar, A. / Llopart, J. / Ibañ / ez, J. et al. | 2012
-
PHS15 Recommendation for Rotavirus Vaccination and Herd Effect: Analyzing Cost Data from a German Statutory Health InsuranceKarmann, A. / Lukas, D. / Jurack, A. et al. | 2012
-
PHS37 Cost Minimization Analysis in the Treatment of Community Acquired Pneumonia in UkraineVadziuk, I. / Markiv, I. / Klishch, I. et al. | 2012
-
PHS43 Cost-Effectiveness Analysis of Therapeutic Drug Monitoring in Pediatric Patients Diagnosed With Structural-Metabolic EpilepsySalih, M. R. / Bahari, M. B. / Shafie, A. A. / Ahmad hassali, M. A. / Al-lela, O. Q. / Abd, A. Y. / Ganesan, V. et al. | 2012
-
PHS51 Hospital Stays of Multiple Sclerosis Patients in Germany – Reasons, Frequencies, Duration and Impact on Drug TherapySeiffert, A. / Dippel, F. W. / Sommer, G. / Holz, B. / Trottmann, M. et al. | 2012
-
PIH1 Spontaneous Adverse Drug Reactions Reporting Forms of 55 Different Countries – Evaluation, Comparison, and Quality CheckAbdul Razack, H. I. / Sree, V. et al. | 2012
-
PIH4 Network Meta-Analysis of Pharmacological Interventions to Prevent Venous Thromboembolism Following Elective Knee and Hip Replacement Surgery: Why Extend the Network?Dequen, P. / Kelly, S. / Abrams, K. et al. | 2012
-
PIH14 Cost of Illness in Women with EndometriosisBoströ / m, P. / Lö / vkvist, L. / Gustafsson, M. / Alexandersson, O. / Bruse, C. / Liffner, C. / Holmberg, J. / Edlund, M. et al. | 2012
-
PIH34 Identifying Individuals with Different Time Preferences in Time Trade-Off Valuations of Hypothetical Health States: A Latent Class Analysis of the US EQ-5D-3L Valuation DataLuo, N. et al. | 2012
-
PND1 12-Month Clinical Evolution of Moderate Alzheimer'S Disease Patients in Spain: The Evocost StudyFrank-Garcia, A. / Salva, A. / Lereun, C. / Gimeno, V. / Milea, D. / Bineau, S. et al. | 2012
-
PND25 Burden of Spina Bifida (SB) in Germany - the Characteristics of SB PopulationSchroeder, A. / Joeckel, M. / van Nooten, F. / Lindemann, M. / Lambrelli, D. / Eriksson, D. / Raluy, M. / Wasiak, R. / Stein, R. et al. | 2012
-
PND59 Cross-Cultural Validation of the Huntington'S Disease Quality of Life Battery for Carers in France and ItalyDorey, J. / Aubeeluck, A. / Squitieri, F. / Clay, E. / Stupple, E. J. / De Nicola, N. / Buchanan, H. / Martino, T. / Toumi, M. et al. | 2012
-
PRS24 Cost-Effectiveness of Varenicline Compared With Bupropion and NRT (Nicorette) for Smoking Cessation in AustriaWalter, E. / Mercsanits, D. et al. | 2012
-
PRS23 Pharmacoeconomic Analysis of Roflumilast for Treatment of Adult Patients With Severe-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)Margieva, A. / Omelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Zorin, N. / Andreyeva, N. et al. | 2012
-
PRS26 Economic Evaluation of Omalizumab in Patients With Uncontrolled Severe Allergic Asthma From the Public Payer Perspective in BrazilSuzuki, C. / Pepe, C. / Silva, N. L. et al. | 2012
-
PRS27 One-Year Cost-Effectiveness of Montelukast in 2-6-Year-Old Children With Mild-Moderate Persistent Asthma in BelarusKozhanova, I. / Romanova, I. / Gavrilenko, L. / Sachek, M. et al. | 2012
-
PRS37 Quality of Life in Paediatric Asthma From Patient and Their Parents PerspectiveMeszaros, A. / Bodná / r, R. / Kadar, L. et al. | 2012
-
PSS5 Bevacizumab Versus Ranibizumab for Age-Related Macular Degeneration (AMD): A Budget Impact AnalysisZimmermann, I. / Schneiders, R. E. / Mosca, M. / Alexandre, R. F. / do Nascimento, J. M. / Gadelha, C. A. et al. | 2012
-
PSS26 Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): An Integrated Approach of Outcomes Measurement in Nail PsoriasisAugustin, M. / Blome, C. / Costanzo, A. / Dauden, E. / Ferrandiz, C. / Girolomoni, G. / Gniadecki, R. / Iversen, L. / Menter, A. / Michaelis-Wittern, K. et al. | 2012
-
PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis: Transit Week 52 ResultsReich, K. / Puig, L. / Luger, T. / Lambert, J. / Chimenti, S. / Girolomoni, G. / Nicolas, J. F. / Kragballe, K. / Mistry, S. / Bergmans, P. et al. | 2012
-
PSS29 Assessing the Clinical Meaningfulness of 1-Line Average Change in Visual Acuity Among Patients With Diabetic Macular Edema: Evidence From Health-Related Quality of Life ChangesLiu, Y. / Liu, C. C. / Campbell, J. / Li, X. Y. / Hashad, Y. / Kowalski, J. W. et al. | 2012
-
CN2 How Early-Stage Non-Persistence and Non-Adherence to Adjuvant Hormonal Therapy Associated With Postmenopausal Breast Cancer Mortality in TaiwanHsieh, K. P. / Chen, L. C. / Chang, C. S. / Yang, Y. H. et al. | 2012
-
DB3 Indirect Treatment Comparison (ITC) or Cost-Effectiveness Analysis (CEA): a StudyKim, H. / Gurrin, L. / Liew, D. et al. | 2012
-
PR3 Utility Values for Chemotherapy-Related Adverse Events: A Review of the LiteratureShabaruddin, F. H. / Chen, L. C. / Elliott, R. / Payne, K. et al. | 2012
-
PHP18 Introducing the Western P&MA Model in the Middle East: UAE as a Case StudyKirpekar, S. / Ismail, A. et al. | 2012
-
PHP26 Consumption of Antidiabetics in Serbia in 2010: A Comparison with Croatia and DenmarkPavlović / N. / Stanimirov, B. / Stojanč / ević / M. / Paut Kusturica, M. / Sabo, A. / Tomić / Z. et al. | 2012
-
PHP31 Knowledge and Practice of Disposal of Date Expired and Unused DrugsMuragundi, P. M. / Priyendu, A. / Janodia, M. / Ligade, V. S. / Udupa, N. / Naik, A. N. et al. | 2012
-
PHP42 Do Macroeconomic Conditions Explain Drug Price Variations Across Countries? A Cross-Sectional AnalysisTsang, K. P. / Wang, B. C. / Patel, P. et al. | 2012
-
PHP48 Health Financing for Prisoners with HIV: Lesson Learned from IndonesiaRifai, M. N. et al. | 2012
-
PHP85 The Use of Biomarkers in Cancer Trials in AsiaHamerslag, L. / Wilson, T. J. / Brooks-Rooney, C. et al. | 2012
-
PHP111 Development of National Medicine Brand Substitution Guidelines and Pilot Assessment of Its Adoptability among Community Pharmacist and General Practitioners in the State of Penang, MalaysiaHassali, M. A. / Shafie, A. A. / Saleem, F. / Atif, M. / Masood, I. / Chua, G. N. / Haq, N. et al. | 2012
-
PHP115 Geographical Distribution of Pharmacies Versus Population: The Case of Two Capital Cities in IranKheirandish, M. / Gharibnaseri, Z. / Kebriaeezadeh, A. et al. | 2012
-
PCV28 Cost-Effectiveness of Presentation and Delayed Troponin Testing for Acute Myocardial InfarctionThokala, P. / Goodacre, S. W. et al. | 2012
-
PCV34 Health-Related Quality of Life in Chinese Patients with Stable Angina PectorisHan, Y. / Wu, J. / Xu, J. / Cong, H. / Zheng, J. / Sun, H. et al. | 2012
-
PGI11 Association Between Knowledge and Health Related Quality of Life in Hepatitis B PatientsHaq, N. / Hassali, M. A. / Shafie, A. A. / Saleem, F. / Aljadhey, H. / Atif, M. et al. | 2012
-
PIH10 Utility Values for Use in Health Care Decision Making for Older Frail AdultsComans, T. A. / Scuffham, P. A. / Gray, L. / Peel, N. et al. | 2012
-
PSS1 Nicotine as a Indicator of Tobacco Exposure and its Effect on Oral HealthKatpattil, S. S. et al. | 2012
-
PRM3 Standard Cost List for Economic Evaluation in ThailandRiewpaiboon, A. et al. | 2012
-
PRM18 Modeling Long-Term Health Outcomes in Chronic Kidney DiseaseLevy, A. R. / Johnston, K. / Sullivan, S. D. / Schnitzler, M. / Sood, V. / Agnese, W. / Osenenko, K. M. / Perkins, R. M. et al. | 2012
-
PRM25 First Drive-Through Pharmacy Service in TaiwanWang, H. Y. / Huang, Y. C. / Chien, H. Y. et al. | 2012
-
PRM27 Feasibility, Comparability, and Reliability of the Standard Gamble Compared With the Rating Scale and Time Trade-Off Techniques in the EQ-5D-5L Valuation StudyKim, S. H. / Lee, S. I. / Jo, M. W. et al. | 2012
-
PCN30 Use of Mind Body Complementary Therapies (MBCTs) Among Malaysian Oncology PatientsFarooqui, M. / Hassali, M. A. / Knight, A. / Akmal, A. / Farooqui, M. A. et al. | 2012
-
PDB2 Epidemiology, Patient Burden and Related Costs of Obesity in IndiaWojciechowski, P. / Metz, L. / Mapari, J. / Jain, M. / Neoh, K. / Caban, A. / Gaweska, M. / Gomulka, A. / Plisko, R. / Wladysiuk, M. et al. | 2012
-
PDB7 Network Meta-Analysis of Fixed Dose Combination Therapies for the First-Line Treatment of Type 2 Diabetes MellitusJindal, R. / Gupta, J. / Arora, A. / Kaur, M. / Kumar, R. / Kaushik, P. et al. | 2012
-
PDB24 Cost- Effectiveness Analysis of Pregabalin in the Treatment of Diabetic Peripheral NeuropathyHashemi Meshkini, A. / Keshavarz, K. / Gharib Naser, Z. / Nikfar, S. et al. | 2012
-
PIN3 Evaluation of the Relationship Between Vancomycin Trough Concentration and Clinical Outcome in Hospitalized Patients With Orsa Bacteremia and the Relationship Between Vancomycin Trough Concentration and NephrotoxicityKuo, C. N. / Chang, C. M. / Chou, C. H. et al. | 2012
-
PIN12 The Analysis for Inpatients Cost and Medical Insurance Coverage of Pneumonia in China, 2009Song, S. F. / Ye, L. / Shi, Q. et al. | 2012
-
PMH13 Dementia and Alzheimer'S Disease in China: Characterization and Caregiver BurdenTang, B. / Harary, E. / Kurzman, R. / Mould, J. / Pan, S. / Kaminsky, R. / Yang, J. et al. | 2012
-
PMS18 Impact of Etanercept-Methotrexate Therapy on Patient-Reported Outcomes in Moderately Active Rheumatoid Arthritis (RA) Patients of Europe, Latin America, and AsiaSzekanecz, Z. / Yen, J. H. / Miranda, P. / Szumski, A. / Bananis, E. / Kotak, S. / Rahman, M. / Tang, B. et al. | 2012
-
PMS20 Patients Reported Outcomes in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated With Golimumab: Sub-Analysis of Asia Population Enrolled in Multicentre Phase Iii Clinical TrialsGenovese, M. / Deodhar, A. / Hsia, E. / Hsu, B. / Lin, Y. J. / Han, C. et al. | 2012
-
PMS23 Health Related Quality of Life, Measured by the Short Form-36, of Patients with Rheumatoid Arthritis and Ankylosing Spondylitis in an Urban Population of ChinaHe, D. Y. / Yao, C. / Zhao, N. / Ning, Y. / Han, C. et al. | 2012
-
PND3 The Population-Based Impact of MS in AsiaLee-Grossman, C. W. / Saunders, W. B. / Wilson, L. S. / Zhong, L. et al. | 2012
-
PSY5 Estimating the Prevalence of Fibromyalgia and Its Impacts on Health in Thais: A Community-Survey in Bangkok, ThailandPrateepavanich, P. / Petcharapiruch, S. / Leartsakulpanitch, J. et al. | 2012
-
PSY16 Cost Utility Analysis of Reduced Intensity Hematopoietic Stem Cell Transplantation in Adolescence and Young Adult With Severe Thalassemia Compared to Hypertransfusion and Iron Chelation ProgramSruamsiri, R. / Chaiyakunapruk, N. / Pakakasama, S. / Sirireung, S. / Sripaiboonkij, N. / Bunworasate, U. / Hongeng, S. et al. | 2012
-
PHP45 Impact of Generics Policy on the Generic PenetrationAmmar, H. / Ré / muzat, C. / Toumi, M. et al. | 2012
-
PHP92 Stakeholders's Views on Recently Introduced Measures to Promote Generics Consumption in GreeceKarampli, E. / Tsiantou, V. / Mylona, K. / Skroumpelos, A. / Pavi, E. / Kyriopoulos, J. et al. | 2012
-
PHP116 Orphan Drug Pricing and Access – Current Situation and Future Trends in EUJeffery, M. / White, R. et al. | 2012
-
PHP123 Importance of Health-Related Quality of Life As an Endpoint in Benefit Assessment According to the German AMNOGKoester, C. / Kossmann, B. / Boehm, K. / Wasem, J. / Aidelsburger, P. et al. | 2012
-
PHP125 An Early Assessment of the German Federal Joint Commission Resolutions of Additional Clinical BenefitMcBride, D. / Kilburg, A. / Mauskopf, J. et al. | 2012
-
PHP138 Impact of Value Based Pricing on Future of Patient Access Schemes in the UKIzmirlieva, M. / Walker, S. / Marinoni, G. / Ando, G. et al. | 2012
-
PHP143 Exploratory Test of Stakeholder Theory in the Implementation Process of It-Innovations in Hospital CareLambooij, M. S. / Hummel, M. et al. | 2012
-
PHP167 The Role of Decision-Analytic Modeling in German Health Technology AssessmentsKuhlmann, A. / Braun, S. / Schulenburg, J. M. et al. | 2012
-
PHP179 Evaluation of Prescribing Practices of Clinicians in Government Teaching Hospital in PakistanAkhtar, M. / Ahmad, M. / Ahmad, I. et al. | 2012
-
PHP184 Changing Margins in Pharmaceutical Distribution: Who Benefits from the New Slicing of the Pie?Barros, P. P. / Martins, B. / Moura, A. et al. | 2012
-
PHP198 From Science to Service: The Ontario Patient Reported Outcomes of Symptoms and Toxicity (On-PROST) Research UnitHowell, D. / Perez Cosio, A. / Liu, G. / Rodin, G. / Hope, A. et al. | 2012
-
PHP204 Appropriate Methods for Economic Evaluation of Programmes with Costs and Effects Extending Across SectorsWalker, S. / Griffin, S. / Claxton, K. / Palmer, S. / Sculpher, M. J. et al. | 2012
-
PGI2 Infliximab Reduces the Risk of Surgical Interventions and Hospitalization in Patients With Inflammatory Bowel DiseaseCosta, J. / Alarcã / o, J. / Caldeira, D. / Borges, M. / Vaz Carneiro, A. et al. | 2012
-
PGI3 Treatment of Chronic Hepatitis C Genotype 1 in Poland – Real-Life DataKaczor, M. P. / Pawlik, D. / Wó / jcik, R. / Rolka, M. / Maniszewska-Weyher, I. / Tronczynski, K. et al. | 2012
-
PGI7 Adherence to 5-Aminosalicylic Acid (5-ASA) Therapies in Ulcerative Colitis (UC): A UK Budget Impact AnalysisSzende, A. / Neves, D. / McDermott, J. D. / Yen, L. et al. | 2012
-
PHP54 Chemical Drug Price Index StudyChang, F. / Zhu, D. / Zhao, Z. / Yang, Z. et al. | 2012
-
PMH10 Patient Persistence With Buprenorhine/Naloxone Film and Tablet Formulations in the Treatment of Opioid Dependence in the United States: Results From a Large Privately Insured Retrospective DatabaseClay, E. / Ruby, J. / Aballea, S. / Zah, V. et al. | 2012
-
PMH16 Analysis of the Economic Burden and Cost Structure of Schizophrenia in Germany Using Observational Sickness Fund DataFrey, S. / Linder, R. / Stargardt, T. et al. | 2012
-
PMH31 Genetic Testing in Combination With Preventive Donepezil Treatment for Amnestic Mild Cognitive Impairment Patients: An Exploratory Economic Evaluation of Personalized MedicineDjalalov, S. / Yong, J. / Beca, J. / Black, S. / Saposnik, G. / Musa, Z. / Siminovitch, K. / Moretti, M. / Hoch, J. et al. | 2012
-
PMD5 Clinical and Cost-Effectiveness of Third-Generation, Implantable Left Ventricular Assist Devices for People With End-Stage Heart Failure: A Systematic ReviewJaworska, E. / Wlodarczyk, A. / Budasz-Swiderska, M. et al. | 2012
-
PMD11 The Cost of Poor Sample Quality: Assessing the Financial Impact of Sample Rejection and Recollection in Health Care InsitutionsChait, G. / Schleuter, K. / Scraba, K. / Baginska, E. / Flynn, L. / Church, S. et al. | 2012
-
PMD51 Cost-Effectiveness of a Predictive Test of the Benefit of ChemotherapyLaas, E. / Vataire, A. L. / Aballea, S. / Gligorov, J. / Rouzier, R. / Ché / reau, E. et al. | 2012
-
PMD69 Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation in the UKRizzo, J. A. / Mallow, P. / Cirrincione, A. et al. | 2012
-
PMD71 The Switch Study: The Impact of Continuous Glucose Monitoring on Health Care Resource UtilizationDe Portu, S. / Castaneda, J. / Hommel, E. / Olsen, B. S. / Battelino, T. / Conget, I. / Schutz-Fuhrmann, I. / Hoogma, R. / Schierloh, U. / Sulli, N. et al. | 2012
-
PMD73 Quality of Life and Resource Use After Transcatheter Aortic Valve Implantation. Preliminary Results of an Observational Multicentre StudyRibera, A. / Ferreira-Gonzá / lez, I. / Slof, J. / Cascant, P. / Abdul-Jawad, O. / Marsal, J. R. / Garcia del Blanco, B. / Serra, V. / Falces, C. et al. | 2012
-
PCV4 The Optimal Interval of Framingham Risk Score to Detect Cardiovasular Disease in Healthy Adults: A Large Cohort Study in JapanTakahashi, O. / Ohde, S. / Deshpande, G. A. / Fukui, T. et al. | 2012
-
PCV5 Comparison of Atrial Measurements and Estimations of Transmitral Regurgitation Using Three-Dimensional and Conventional Echocardiography in DogsPoulsen Nautrup, B. / Schultheiss, S. / Poulsen Nautrup, C. et al. | 2012
-
PCV10 Cost-Effectiveness of Extended Duration Thromboprophylaxis After Surgical DischargeIannuzzi, J. C. / Rickles, A. S. / Fleming, F. J. / Monson, J. R. / Noyes, K. et al. | 2012
-
PCV40 Pharmacotherapy Cost of Patients With Hypertension in BulgariaMarinov, L. / Kamusheva, M. / Nikolova, I. / Petkova, V. / Petrova, G. et al. | 2012
-
PCV47 Economic Evaluation of Dabigatran for Stroke Prevention Among Patients With Atrial Fibrillation in the NetherlandsLe, H. H. / Pechlivanoglou, P. / Engelfriet, P. M. / Postma, M. J. / Redekop, W. K. et al. | 2012
-
PCV62 Clinical and Economic Analysis of the Effectiveness of Antihypoxia Substance Polydihydroxyphenylenethiosulfonate Sodium (Hypoxenum) in the Complex Angina Pectoris TreatmentVorobiev, P. / Luneva, A. et al. | 2012
-
PCV77 Analysis of Hospital-Specific Drg Payments for Stroke According to United States Medicare PerspectiveBlein, C. / Marty, R. / Roze, S. et al. | 2012
-
PCV112 Dosage Analysis of CHF Therapies on the Basis of Hungarian Claim DatabaseTó / th, E. / Kovacs, E. / Nagy, B. et al. | 2012
-
PCV116 Impact of the Type of Drug Insurance on Cost of Statins and Anti-DepressantsBlais, L. / Kettani, F. Z. / Forget, A. et al. | 2012
-
PIN9 Contraindications to Hepatitis C Treatment: Which Ones Modify the Likelihood of Veterans Receiving Treatment?Lafleur, J. / Lin, J. / Xie, Y. / Hayden, C. / DuVall, S. / Nelson, R. E. et al. | 2012
-
PIN16 Tuberculosis Treatment Outcomes in Patients With and Without Diabetes MellitusKhan, A. H. / Sulaiman, S. A. / Abdul Muttalif, A. R. / Hassali, M. A. / Ahmad, N. et al. | 2012
-
PIN19 A Budget Impact (BI) Analysis of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to No Vaccination (NoVac) or 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in the UKJiang, Y. / Gauthier, A. / Keeping, S. T. / Carroll, S. M. et al. | 2012
-
PIN30 Varicella, a Cost of Illness Hungarian StudyTó / th, E. / rsek, K. et al. | 2012
-
PIN54 Evaluation of Skin Tests in the Diagnostics of Tuberculosis InfectionYagudina, R. / Kulikov, A. / Zinchuk, I. et al. | 2012
-
PIN61 The Cost-Utility of Telaprevir in Combination With Peginterfeon Alpha and Ribavirin (PR) as Compared to the Combination Boceprevir With PR and to PR Alone in the Management of Chronic Hepatitis C in the NetherlandsVellopoulou, K. / Van Agthoven, M. / Van Der Kolk, A. / Lamotte, M. / Cure, S. / Bianic, F. et al. | 2012
-
PSU32 A Comparison of Resource Utilization and Medical Charges Among Lumbar Interbody Fusion Surgical Patients With and Without RevisionKemner, J. E. / Lage, M. J. / Treglia, M. et al. | 2012
-
PSU35 Epidemiological Modeling of Patient Survival After Heart Transplantation in GermanyJugl, S. / Langsdorf, V. / Schü / le, S. et al. | 2012
-
PSU36 Evidence Based Medicine: A Case Study of its Application to Innovative Surgical Procedures in the UKMauskopf, J. / Beach, W. / Mcintyre, L. / Bhattacharyya, S. K. / Higgins, L. / Mordin, M. / Copley-merriman, K. et al. | 2012
-
PCN13 Analysis of the Impact of Prophylactic Vaccination Against Human Papillomavirus Infection Using a Dynamic-Modelling ApproachWestra, T. / Nijman, H. / Wilschut, J. / Daemen, T. / Postma, M. et al. | 2012
-
PCN20 Inhaled Corticosteroid Use and Risks of Lung Cancer and Laryngeal CancerHyun, M. K. / Lee, C. H. / Jang, E. J. / Lee, N. R. / Kim, K. / Yim, J. J. et al. | 2012
-
PCN100 Cost Utility Analysis of Bortezomib in a Biomarker Positive Subgroup of Relapsed and Refractory Folicular LymphomaVandekerckhove, S. / Lamotte, M. / Iannazzo, S. / Chirita, O. et al. | 2012
-
PCN119 Patient-Reported Outcomes (PROs) in Antineoplastic Product Approvals in Europe and in the USAPatrick, D. / Acquadro, C. / Teschendorf, B. / Emery, M. P. / Caron, M. / Arnould, B. et al. | 2012
-
PCN141 Health Care Utilization (HCU) by Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) Patients with Chemotherapy Induced Febrile Neutropenia (FN) in the NetherlandsIssa, D. E. / van Herk-Sukel, M. P. / Gelderblom, H. / Houweling, L. M. / Jager, A. / De La Orden, M. / Lugtenburg, P. J. / van der Werf-Langenberg, M. E. / Nortier, J. W. / de Jong, F. A. et al. | 2012
-
PCN144 Access to Cancer Interventions Across the UK: To What Extent Does SMC Advice Agree with Nice'S End-of-Life Therapies?Hamerslag, L. / Brooks-Rooney, C. et al. | 2012
-
PMS14 Impact of Severity Index for Rheumatoid Arthritis on Health Care Costs and Utilizations in Patients With Rheumatoid ArthritisBaser, O. / Wang, L. / Du, J. / Wang, H. / Xie, L. et al. | 2012
-
PMS37 Economic Evaluation Model of Biologic Therapies for Moderate to Severe Psoriatic Arthritis in GermanyWang, X. / Bansback, N. / Anis, A. / Joshi, A. D. / Rao, S. / Wolff, M. / Cifaldi, M. et al. | 2012
-
PUK22 Evaluating the Minimum Renal Allograft Survival Time Required for Transplantation to Remain Cost Saving in the UKMcEwan, P. / Lebmeier, M. et al. | 2012
-
PRM13 Methods for Estimating Survival Benefits in the Presence of Treatment Crossover: A Simulation StudyLatimer, N. / Lambert, P. / Crowther, M. / Abrams, K. R. / Wailoo, A. J. / Morden, J. P. et al. | 2012
-
PRM30 Hospitalization Registry and Costs of Benign Prostatic Hyperplasia Patients (BPH) Based on a Public Database (DATASUS) in BrazilBarbosa, E. G. / Lowery, A. P. / Santos, P. A. / Machado, M. et al. | 2012
-
PRM36 Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID): Evolution of Content, Structure, and Functionalities (2002-2012)Emery, M. P. / Caron, M. / Perrier, L. L. et al. | 2012
-
PRM40 Efficacy of Liraglutide Compared to Exenatide and Insulin Glargine in Patients With Diabetes Type 2: A Meta-AnalysisFadipe, J. J. et al. | 2012
-
PRM60 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for 1st- Line Chronic Myeloid LeukaemiaHoyle, M. / Pavey, T. / Ciani, O. / Crathorne, L. / Jones-Hughes, T. / Cooper, C. / Osipenko, L. / Venkatachalam, M. / Rudin, C. / Ukoumunne, O. et al. | 2012
-
PRM67 The Use of Health Economic Models in Hungarian Health Technology AssessmentNemeth, B. / Borsi, A. et al. | 2012
-
PRM78 Mapping of the National Eye Institute 25-Item Visual Functioning Questionnaire (VFQ-25) to EQ-5D Utility ScoresKay, S. / Ferreira, A. et al. | 2012
-
PRM90 Outcome Differences in Algorithms Used for Indirect Mapping of Utility Values From HAQ-DI: An Assessment Based on Phase 2A Clinical Trial Data in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-II-20 MAB)Strandberg-Larsen, M. / Hansen, B. B. / Gö / thberg, M. / Valencia, X. et al. | 2012
-
PRM100 Converting EORTC QOl-C30 Scores to Utility Values: Is it Plausible?Salek, M. S. / Schmidt-Rimpler, C. / Wimberger, P. / Gilet, H. / Parsons, S. L. et al. | 2012
-
PCV120 The Factors Which Affect the Price of Antihypertensive Combinations Including Angiotensin Receptor BlockersBerktas, M. / Guclu, H. / Ozbay, L. / Sencan, N. et al. | 2012
-
PIN23 Economic Analysis of Atazanavir as 1st Line Treatment for VIH Patients, on Stable and Sever Health StateBetegon, L. / Hidalgo, A. / Villoro, R. / Ivanova, A. / Woolmore, A. et al. | 2012
-
PIN51 Health Economic Evaluation of the Vaccination Against Herpes Zoster and Postherpetic Neuralgia in GermanyUltsch, B. / Reinhold, T. / Siedler, A. / Krause, G. / Wichmann, O. et al. | 2012
-
PIN58 Cost Per Sustained Virological Response of Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients According to the Previous Treatment Response and the Metavir Groups in BrazilMorais, A. D. / Pereira, M. L. et al. | 2012
-
PIN68 Cost-Minimization Analysis of Caspofungin Versus Liposomal Amphotericin B for the Treatment of Febrile, Neutropenic Patients With a Presumed Fungal Infection in the NetherlandsCharokopou, M. / Majer, I. M. / Van der Waal, J. M. / Verheggen, B. G. et al. | 2012
-
PIN87 Lengt of Stay and Costs for Patients With Recurrent Clostridium Difficile Infections in SwedenNoré / n, T. / Bruce, S. / Fagerlund, K. / Nordling, S. et al. | 2012
-
PSU13 Survival and Cost Comparison of Balloon-Kyphoplasty and Vertebroplasty Using German Claims DataLange, A. / Kasperk, C. / Braun, S. et al. | 2012
-
PSU16 High Cost Patients for Cardiac Surgery and Hospital Quality in TurkeyBaser, O. / Burkan, A. / Baser, E. / Koselerli, R. / Ertugay, E. / Altinbas, A. et al. | 2012
-
PCN2 Data Analyses on Prevalence and Treatment of Acute Myeloid Leukaemia in GermanyTomeczkowski, J. / Theidel, U. / Mittendorf, T. / Fleischmann, J. / Tapprich, C. et al. | 2012
-
PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)Lothgren, M. / Hechmati, G. / Jacobs, I. / Qian, Y. / Arellano, J. et al. | 2012
-
PCN35 Survival Estimates of Six Major Advanced and Metastatic Solid Tumors in Europe: A Cancer Registry and Literature ReviewMoulard, O. / Mehta, J. / Rose, M. / Olivares, R. / Hamed, A. / Eckert, L. et al. | 2012
-
PCN40 Year to Year Budget Impact Analysis of Biological Therapies for First-Line Treatment of Metastatic Colorectal Cancer in SpainMartí / nez-Amores, B. / Mezquita, L. / Ibá / ez de Cá / ceres, I. / Ayuso, x. / Peñ / a, J. M. / Perona, R. et al. | 2012
-
PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate CancerWolff, J. M. / Donatz, V. / Klier, J. / Erhardt, W. / Dass, R. N. / Geiges, G. et al. | 2012
-
PCN132 Duration of Gefitinib Treatment in EGFR Mutation Positive NSCLC Patients in a UK Single Payement Access Scheme (SPA)Vioix, H. / Franzen, S. / Selby, D. / Hauch, O. / Emmas, C. E. et al. | 2012
-
PCN140 The Evaluation of Health Care Resource Utilization in Patients With Metastatic Castration Resistant Prostate Cancer: Results of a Multinational Observational StudyDass, R. N. / Hamberg, P. / Spencer, M. / Wheatley price, P. et al. | 2012
-
PMS16 Economic Burden of Juvenile Idiopathic Arthritis in RussiaDerkach, E. V. / Omelyanovsky, V. / Avxentyeva, M. / Ivakhnenko, O. / Ignateva, V. et al. | 2012
-
PMS27 The Method for Reversing Anticoagulation Affects Treatment Costs and May Decrease Mortality Among Hip Fracture Patients Using WarfarinAgthe, N. / Purmonen, T. / Kokki, H. et al. | 2012
-
PMS33 Cost-Efficacy Analysis of Biologic Drugs in Combination With DMARDs in Patients With Active Rheumatoid Arthritis and Inadequate Response to Traditional DMARDs in Portugal – A Simplified ApproachCafe, A. / Monteiro, I. / Loff, J. F. / Encarnaç / o, R. et al. | 2012
-
PMS43 Cost-Effectiveness of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in the Treatment of Severe Active RACarlson, J. J. / Ogale, S. / Dejonckheere, F. / Sullivan, S. D. et al. | 2012
-
PMS45 Exercise Therapy, Manual Therapy, or Both, for Management of Osteoarthritis of the Hip or Knee: Economic Evaluation Alongside a Randomized Clinical TrialAbbott, J. H. / Pinto, D. / Robertson, M. C. et al. | 2012
-
PMS48 Tocilizumab in Methotrexate-Intolerant or Contraindicated Patients – A Cost-Utility Model for the UKHarland, D. / Gibbons, C. / Diamantopoulos, A. / Pang, H. / Huertas, C. / Dejonckheere, F. et al. | 2012
-
PMS49 Cost-Effectiveness Analysis of Etanercept and Infliximab in the Treatment of Rheumatoid Arthritis (RA) in SpainGuijarro, P. / Crespo, C. / Brosa, M. et al. | 2012
-
PUK7 Cost of Illness of Overactive Bladder Syndrome in HungaryBrodszky, V. / Gulá / csi, L. / Majoros, A. / Piró / th, C. / Bö / szö / rmé / nyi-Nagy, G. et al. | 2012
-
PUK20 Development of a Patient Adherence Specific Scale for Use in the Management of Benign Prostatic Hyperplasia PatientsAmarenco, G. / Haab, F. / Benjamin, L. / Slama, A. / Dias barbosa, C. / Ruttkay, Y. / Bergmann, J. F. et al. | 2012
-
PRM2 Assessing Relative Clinical Value Within Three Metastatic DiseasesKarweit, J. / Wolfe, S. / Kotapati, S. / Lees, M. / Abernethy, A. P. et al. | 2012
-
PRM8 Treatment of Rheumatoid Arthritis – Comparative Effectiveness of BiologicsSchiffner-Rohe, J. / Leverkus, F. / Behmer, O. S. / Kerkmann, U. et al. | 2012
-
PRM47 Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect InformationCampbell, J. / McQueen, R. B. / Libby, A. M. / Spackman, E. / Carlson, J. / Briggs, A. et al. | 2012
-
PRM49 EQ-5D Versus Disease-Specific HR-QoL Instruments – No Contest?Ratcliffe, A. E. / Ratcliffe, M. et al. | 2012
-
PRM55 Third Party Model Validity: A Review and Survey of Face and Internal Validity of Health Economic ModelsBecker, R. V. et al. | 2012
-
PRM56 Development of a Conceptual Model for Use in Economic Modelling of Chronic Obstructive Pulmonary Disease (COPD)Gonzalez McQuire, S. / Tabberer, M. / Muellerova, H. / Briggs, A. / Lomas, D. / Rutten-van Mö / lken, M. P. / Chambers, M. et al. | 2012